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3Overview
This thesis investigated biases in the implicit processing of substance-related
cues in substance users. Part 1, a literature review, assessed the effectiveness of
attempts to modify such processes and the wider benefits of doing so. The 12 studies
reviewed, addressing between them attentional bias, implicit attitudes and approach
bias in either alcohol drinkers or tobacco smokers, suggest that implicit processes are
readily modifiable. However, the evidence of wider benefit is less clear. The clinical
implications and future research considerations are discussed.
Part 2 is an empirical paper, conducted jointly with a fellow trainee clinical
psychologist, which assessed the effects of attentional bias modification (ABM) in
opiate dependent and non-substance using control participants. Baseline differences
in attentional bias (AB) between these groups were assessed, as were the effects of
ABM on AB and craving. The role of treatment adherence (i.e. whether or not an
individual was using illicit opiates on top of their prescribed substitute) was also
explored. Contrary to predictions, there were no baseline group differences in AB,
and ABM had no significant effects on AB or craving. However, treatment
adherence was an important factor, with differences found between opiate dependent
participants using on top, not using on top and control participants on measures of
AB, craving and psychopathology. The clinical and research implications of these
differences are discussed.
Finally, Part 3, the critical appraisal, provides reflections on the entire
research process. Some guidance and recommendations are also offered to future
researchers covering areas such as the difficulties in recruiting from these clinical
populations, and possible alternative approaches to the problem of biases in implicit
processes in substance use.
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Abstract
Aim: This review examined whether interventions that aim to modify implicit
processes in substance users significantly alter them, and whether there is any
additional clinically relevant benefit of such interventions.
Method: Studies were included if they (a) primarily aimed to modify any facet of
implicit cognition in individuals who use substances, (b) assessed the effects of the
intervention on at least that same facet of implicit cognition, and (c) assessed the
effects of the intervention on clinically relevant outcomes. Twelve studies were
selected for review.
Results: Eleven of the 12 studies reviewed found that the intervention produced
significant change in the predicted direction on the implicit process it targeted.
Evidence of any additional benefit of intervention was mixed. In community
samples, interventions targeting implicit attitudes and approach bias produced
significant change in clinically meaningful outcomes, although some findings were
suggestive of a protective effect of intervention against repeated exposure to
substance-related stimuli. Results of the two studies targeting attentional bias and
approach bias in clinical samples were positive, with some evidence of the
intervention influencing treatment outcome.
Conclusion: Interventions targeting implicit processes show promise in bringing
about change in substance use behaviour. Benefits are perhaps most evident for
clinical populations. However, the research is in its infancy and to date includes only
two studies with clinical populations, and only alcohol and tobacco users have been
examined. Replication of current findings is therefore needed, and further research
should also aim to examine users of other substances, determine the benefits of
single versus multiple intervention sessions, and determine whether these
interventions can serve a protective role in at-risk populations.
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1. Introduction
In the UK, substance use is common, with over a third of adults reporting
having ever taken an illicit substance in their lives, and 5.2% having taken at least
one in the past month (Health and Social Care Information Centre (HASCIC),
2012a). These figures are much higher for legal substances such as alcohol (with
68% of men and 54% of women reporting drinking in the past week; HASCIC,
2012b) and tobacco (with 20% of adults reporting regular smoking; HASCIC,
2012c). Furthermore, substance use and misuse represents a significant burden on the
National Health Service (NHS), with alcohol use costing the NHS approximately
£2.7bn in 2006/7 (Department of Health (DH), 2008), and tobacco use costing
approximately £5.2bn in 2005/6 (5.5% of total healthcare costs; Allender,
Balakrishnan, Scarborough, Webster & Rayner, 2009).
Given the harm substances can cause on the individual as well as society, the
UK government has specific drug (Home Office, 2010), alcohol (Home Office,
2012) and tobacco (DH, 2011) strategies. However, substance misuse services
continue to report relatively low success rates, with only 13% of adults leaving
treatment dependency free in 2011-2012 (National Treatment Agency for Substance
Misuse, 2012).
Substance use, misuse and dependence have consequently attracted much
research. Substance use has come to be understood as a complex phenomenon, and
our understanding of the multiple factors involved in its development and
maintenance has gradually improved. Over the past 15 years, the importance of
cognitive processes in substance use has become apparent. Therefore, models of
substance use and dependence have attempted to accommodate both the traditional
biological and more recently acknowledged cognitive processes. The most recent
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models are known as dual process models (e.g. Deutsch & Strack, 2006; Wiers et al.,
2007). A detailed description of these models is beyond the scope of this article so a
brief outline only will be provided here, but interested readers can see Wiers and
Stacy (2006a) for a summary, or Wiers and Stacy (2006b) for a more detailed
account.
Dual process models were developed to explain the paradoxical behaviour
that is repeated substance use, i.e. the fact that individuals continue to take
substances despite their awareness of the risks and consequences of doing so.
Therefore, purely 'rational' explanations of substance use are considered insufficient.
While individual models differ in terms of their specific details, they generally
include two systems, "implicit" and "explicit", as involved in substance use. The
implicit system is relatively automatic, fast and associative, and includes processes
such as attentional bias, motivational and affective memory associations, and
approach bias. The explicit system, is slower, more rational and under conscious
control. It therefore includes executive functions such as decision-making, emotion
regulation, and response inhibition.
The models propose that dependence develops as the result of the emergence
of an imbalance between the two systems over time: an increase in the predominance
of implicit processes (leading to increased salience and motivation to use
substances), accompanied by a decrease in explicit control of such implicit processes.
As dependence develops, executive processes weaken and the behaviour becomes
increasingly stimulus driven and implicit processes dominate, meaning substance use
can be increasingly triggered by factors outside conscious awareness.
This increasing predominance of implicit processing is compatible with
incentive-sensitization theory (Robinson & Berridge, 1993), which outlines the
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neurobiological adaptations that underpin addiction. These adaptations are thought to
give rise to attentional bias leading to motivation to use the drug and subsequent
activation of approach behaviours (Robinson & Berridge, 2003, 2008). Noteworthy
is that both attentional bias and approach bias (a precursor of approach behaviour)
are major features of the implicit system in dual process models.
However, individual differences are important in determining one’s
susceptibility to developing dependence. For instance, trait impulsivity has been
found to predict later addictive behaviour (e.g. de Wit, 2009) and Robinson and
Berridge (1993) posit a moderating role of impulsivity in their theory. Moreover, the
effect of implicit processes on behaviour is weaker in individuals with good
executive control, and vice versa (Grenard et al., 2008; Houben & Wiers, 2009;
Thush et al., 2008).
It would seem then that implicit and explicit processes are interrelated
phenomena and are not entirely independent of one another in their involvement in
substance use. Indeed, a recent meta-analysis of the alcohol literature supports this.
Reich, Below and Goldman (2010) found that while implicit and explicit measures
predict some shared variance in drinking behaviour, each also make a significant
unique contribution. This therefore lends support to dual-process models and means
it is worthwhile addressing implicit as well as explicit processes in both theoretical
accounts and treatment strategies.
Current psychosocial treatments for substance misuse, however, almost
exclusively target explicit cognition alone. For example, contingency management
(e.g. Petry, 2006; an approach recommended by the National Institute for Health and
Clinical Excellence, 2007), involves the explicit reinforcement of specified
behaviours such as reduced substance use. While the evidence-base for some
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psychosocial treatments is strong, it is possible that the effectiveness of interventions
could be enhanced by the addition of an implicit component.
Recent evidence in mood and anxiety disorders suggests that this might
indeed be possible, with favourable clinical outcomes for participants receiving
interventions targeting implicit processes. For example, Hazen and colleagues (2009)
found that an intervention aimed at reducing attentional bias (attentional training) in
pathological worriers successfully reduced their worry as well as other anxiety
symptoms. Similar beneficial effects of attentional bias interventions have been
reported in generalised anxiety disorder (GAD) (Amir, Beard, Burns & Bomyea,
2009), where only 50% of patients who received the attentional training continued to
meet diagnostic criteria for GAD following training compared with 87% of the
control group. In addition, positive outcomes have been reported in social anxiety
(Schmidt, Richey, Buckner & Timpano, 2009; Amir et al., 2009). Here, Schmidt and
colleagues (2009) found a similar result to Amir, Beard et al. (2009), where again,
fewer participants in the attentional training group than the control group met
diagnostic criteria for social anxiety at four-month follow-up (38% and 87%
respectively). There is also evidence that such interventions may act as a protective
factor against depression in individuals who have experienced two or more
depressive episodes in the past (Browning, Holmes, Charles, Cowen & Harmer,
2012).
Following the relative promise of implicit approaches in anxiety and mood
disorders, research has begun to examine the effects of similar interventions in
substance using populations. This review therefore aimed to examine this research to
date. Specifically, it sought to address the extent to which: (a) interventions aimed at
modifying implicit processes can significantly alter them, and (b) there is any
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additional clinical benefit of such interventions, as evidenced by, for example,
reduction in cravings or frequency of substance use.
2. Method
2.1 Literature search
The literature search included the PsycINFO, PubMed, Medline and Embase
databases. Broadly speaking, two categories of keywords were used in the search.
The first category included terms related to implicit cognition and existing
techniques thought to alter implicit cognition. The second category related to
substance use. The results were limited to papers in scientific, peer-reviewed and
English language journals, only. A copy of the full search terms used can be found in
Appendix A.
2.2 Inclusion criteria
In order to be selected, a study had to (a) employ a method that primarily
aimed to modify any facet of implicit cognition in individuals who use substances,
(b) assess the effects of that intervention on at least that same facet of implicit
cognition, and (c) assess the effects of the intervention on other, clinically
meaningful outcomes (e.g. cravings, substance use etc.).
2.3 Study selection
Following the removal of duplicates, the search returned 398 papers. The
titles and abstracts of those papers were then read and checked against the inclusion
criteria above. 379 papers were removed following this check. The remaining 19
papers were then read in full to finalise the study selection. Following this round of
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checks, a further eight studies were removed primarily because the explicit aim of
the intervention was not to modify an aspect of implicit cognition. Reference lists of
the remaining 11 papers were also checked for any additional relevant studies and
this revealed one further paper that was not found in the original literature search.
Twelve papers in total were therefore selected for review.
3. Results
Table 1 summarises the key characteristics of the studies included. As can be
seen, to date, studies employing methods aimed at modifying implicit biases have
largely targeted attentional bias (eight studies), but more recently there have been
approaches targeting alternative implicit processes (implicit attitudes: two studies;
approach bias: two studies). Nine studies focused on alcohol users, and three studies
on tobacco smokers. Only two studies to date have been conducted using a clinical
sample, whereas the remainder recruited community samples with most of these
examining university student populations.
The quality of each study was assessed systematically using a critical
appraisal tool developed by Downs and Black (1998). This checklist is a 27-item
measure spanning five areas, namely the quality of reporting ('reporting'; 10 items),
the generalisability of the study ('external validity'; 3 items), bias in the
intervention(s) and outcome measure(s) ('bias'; 7 items), bias in sampling or group
allocation ('confounding'; 6 items), and statistical power ('power'; 1 item). An overall
'Quality Index' score is calculable, which represents the total score obtained across
all items. The checklist has been shown to generally have good statistical properties,
although the external validity subscale had poor reliability (Downs & Black, 1998).
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Table 1
Key characteristics of the studies included in the review
Authors Sample
Size
Substance Sample type Implicit
cognition
targeted
Intervention
technique
Follow-up
period
Attwood et al.
(2008)
55 Tobacco Universitya Attentional
bias
Modified
visual probe
None
Fadardi &
Cox (2009)
160 Alcohol Community Attentional
bias
Modified
Stroop
3 monthsb
Field et al.
(2007)
60 Alcohol Universitya Attentional
bias
Modified
visual probe
None
Field et al.
(2009)
72 Tobacco Universitya Attentional
bias
Modified
visual probe
None
Field &
Eastwood
(2005)
40 Alcohol Universitya Attentional
bias
Modified
visual probe
None
Houben,
Havermans &
Wiers (2010)
116 Alcohol University
Studentsc
Attitudes/
affective
associations
Evaluative
conditioning
1 weekb
Houben,
Schoenmakers
& Wiers
(2010)
88 Alcohol University
Studentsd
Attitudes/
affective
associations
Evaluative
conditioning
1 weekb
McHugh et al.
(2010)
64 Tobacco Community Attentional
bias
Modified
visual probe
None
Schoenmakers
et al. (2010)
43 Alcohol Clinical Attentional
bias
Modified
visual probe
3 monthse
Schoenmakers
et al. (2007)
106 Alcohol University
Studentsd
Attentional
bias
Modified
visual probe
None
Wiers et al.
(2011)
214 Alcohol Clinical Approach
bias
Approach/
avoidance task
1 week
and 1 yearf
Wiers et al.
(2010)
42 Alcohol University
Studentsd
Approach
bias
Approach/
avoidance task
None
a Sample consisted of staff and students at a university
b Alcohol consumption was monitored over follow-up period
c All participants were assessed via the internet
d The sample was male only
e Data gathered at follow-up were treatment outcome and drinking behaviour only
f Approach bias was assessed at 1 week follow-up, and alcohol and other substance use was assessed
at 1 year follow-up
For its use in the present review, the scoring of item 27 (relating to statistical
power) was modified so that studies scored either ‘0’ or ‘1,’ and studies with
statistical power equal to or greater than 80% were awarded a score of ‘1’.
Consequently, the Quality Index was scored out of a total of 28 points, as opposed to
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the originally intended 32 points. The full item score was awarded for any individual
item which was not applicable to a study.
Table 2 displays the scores obtained on the checklist by each study. The
specific strengths and weaknesses of any study highlighted by the checklist will be
discussed in detail under the relevant section below.
Table 2
Scores obtained by each study on the Downs & Black (1998) critical appraisal tool
Downs & Black subscales
Authors Reporting
(max=11)
External
validity
(max=3)
Bias
(max=7)
Confounding
(max=6)
Power
(max=1)
Total
(max=28)
Attwood et al.
(2008)
9 1 6 5 1 22
Fadardi & Cox
(2009)
9 1 3 2 1 16
Field et al. (2007) 10 1 7 6 1 25
Field et al. (2009) 8 1 7 6 1 23
Field &
Eastwood (2005)
8 1 6 5 1 21
Houben,
Havermans &
Wiers (2010)
9 0 4 4 1 18
Houben,
Schoenmakers &
Wiers (2010)
8 1 5 4 1 19
McHugh et al.
(2010)
10 3 6 5 1 25
Schoenmakers et
al. (2010)
11 3 5 5 1 25
Schoenmakers et
al. (2007)
11 1 6 5 1 24
Wiers et al.
(2011)
9 3 7 6 1 26
Wiers et al.
(2010)
11 1 6 5 1 24
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3.1 Attentional bias
Attentional bias (AB) is the phenomenon whereby disorder-related stimuli
implicitly grab one's attention. AB has consistently been found in individuals who
use substances (see Field & Cox, 2008), and features as an important part of many
models of addiction (e.g. Franken, 2003; Ryan, 2002; Wiers et al., 2007; Wiers &
Stacy, 2006b). Eight studies reviewed here have attempted to modify AB in
substance users. This has been achieved by either the modified visual probe
paradigm, or the modified Stroop task.
3.1.1 Modified visual probe paradigm
Seven studies employed the modified visual probe paradigm to modify
attentional bias (Attwood, O'Sullivan, Leonards, Mackintosh & Munafò, 2008; Field
et al., 2007; Field, Duka, Tyler & Schoenmakers, 2009; Field & Eastwood, 2005;
McHugh, Murray, Hearon, Calkins & Otto, 2010; Schoenmakers et al., 2010;
Schoenmakers, Wiers, Jones, Bruce & Jansen, 2007).
This method follows MacLeod et al. (2002), and while the exact
specifications of the tasks used in each study have varied, the basic principle has
remained unchanged. In this task, participants are presented with two images on the
screen: one a substance-related image, the other a matched neutral image. The
images are followed by a probe – which may, for example, be a single or double
pixel – which appears in the location of one of the images, and participants must
identify the probe type as quickly and accurately as possible by pressing one of two
response keys (see Figure 1 for a representation of a single trial). In the standard
version of the visual probe task, which measures AB, probes replace substance-
related and neutral images equally often. AB is then determined by comparing
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reaction times to the probe when it replaced the substance
neutral images. AB for
significantly faster to respond
images. In the modified version of the task, where AB is
to as attentional bias modification; ABM), the contingency of probe location is
adjusted so that the probe replaces one
example, to train attention
images with probes, so that in order to improve at the task and become faster,
participants should direct th
substance-related stimuli.
3.1.1.1 ABM in alcohol
Four studies (Field et al., 2007; Field & Eastwood,
al., 2010; Schoenmakers et al., 2007) employed this methodology
-related image
a substance would be found where participants are
to the probe when it replaces the substance
trained (hereafter referred
type of image more often than the other. For
away from substances, one would replace the neutral
eir attention toward the neutral stimuli
Figure 1: A visual representation of the sequence of events in a
single trial of the modified visual probe task.
users
2005; Schoenmakers et
21
s versus the
-related
, rather than the
with alcohol users,
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with one study targeting a clinical sample of alcohol dependent patients
(Schoenmakers et al., 2010), and the remainder investigating predominantly student
alcohol drinkers. For comparison, the reported level of alcohol consumption by
participants in each of these studies is given in Table 3. While there is no doubt
participants in Schoenmakers and colleagues’ (2010) clinical sample were drinking
at very high and harmful levels, the level of drinking in the other studies’ samples
was much closer to recommended limits (14 UK units for women and 21 UK units
for men; DH, 2005). Indeed, in the original papers, although the range of the data
was not always provided and the data were not broken down by gender, on balance
the data in Table 3 suggest that the majority of participants in the non-clinical
samples were consuming alcohol at levels towards the lower end of the ‘hazardous’
range (defined as 15-35 UK units for women, 22-50 UK units for men; DH, 2005).
Table 3
Weekly alcohol consumption of participants in the four modified dot-probe ABM
studies recruiting alcohol drinkers
Sample Type Mean (SD) weekly alcohol consumption by group
Attend Alcohol Avoid Alcohol Control
Field et al. (2007) Universitya 21.73 (34.21) 22.05 (23.21) 25.63 (58.76)
Field & Eastwood
(2005)
Universitya 27.65 (12.54) 25.80 (11.76) –
Schoenmakers et
al. (2010)
Clinical 215.6 (16.7)b – 252.7 (28.8)b
Schoenmakers et
al. (2007)
University
Studentsc
50.2 (Range:
26.3-118)
– 50.2 (Range:
26.3-109)
Note: Values are Mean (SD), unless otherwise stated. Alcohol consumption is expressed in UK units.
Data originally not in these units have been converted for comparative purposes.
a Sample consisted of staff and students at a university.
b Data provided in paper are for mean daily consumption for single day prior to admission for
treatment. For comparative purposes, value given in the table is estimated, and was calculated by
multiplying by seven the mean daily consumption figures.
c The sample was male only.
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Across all four studies, ABM aimed at training attention away from alcohol-
related stimuli successfully reduced AB immediately following the intervention.
However, evidence of additional clinical benefit in these 'avoid alcohol' ABM groups
was very limited, with only Schoenmakers et al. (2010) reporting any such benefit. In
their clinical sample, the ABM intervention produced generalisation to novel stimuli
(a finding not found in Field et al., 2007, or Schoenmakers et al., 2007) and
participants in this group were also discharged from treatment significantly earlier
than participants in the control group. The other three studies failed to find any
further benefit of ABM aimed at training attention away from alcohol-related stimuli.
Noteworthy, however, was the 'adverse' effects apparent in those studies employing a
'toward alcohol' control group (i.e. attentional training away from neutral and
towards alcohol-related stimuli). Two of the studies included such control groups,
and found that it increased participants' urge to drink (Field & Eastwood, 2005; Field
et al., 2007) and led to greater alcohol consumption upon a taste test (Field &
Eastwood, 2005, only). Furthermore, Field and colleagues (2007) found that the
training effect in this control group generalised to novel alcohol stimuli; a finding not
found in other groups in the same study or in other studies (with the exception of
Schoenmakers et al., 2010; see above).
The scores obtained by each paper upon critical appraisal (see Table 2)
suggest that in general, all four studies were well designed and well reported. The
three studies using community samples fared poorly on external validity, due to the
fact that they recruited a largely university student sample and one study
(Schoenmakers et al., 2007) recruited men only.
The appraisal highlighted the role of blinding and contingency awareness in
research of this type. Schoenmakers et al. (2010) explicitly informed participants in
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the ABM group that probes would never appear behind alcohol-related images. As a
result, this study had a reduced score on the bias subscale of the appraisal checklist.
In the three other studies, however, no explicit instruction was given and, instead,
awareness was assessed after the study had been completed. Field and Eastwood
(2005) and Schoenmakers et al. (2007) found that awareness in any group did not
affect any of the results. Field et al. (2007), however, did note that awareness was
important in the 'attend alcohol' control group where aware participants experienced
increased craving for alcohol during a taste test. Therefore, awareness was generally
found to be rare and important perhaps only in the control conditions.
Noteworthy is that the variation in the findings between Schoenmakers et al.
(2010) and the three other studies may be attributable to the two major differences in
their design and nature. First, Schoenmakers et al. (2010) used a clinical sample.
Second, participants in that clinical sample were exposed to multiple sessions of
ABM, as opposed to a single session as in the other three studies. This issue will be
discussed further in section 4.1, below.
3.1.1.2 ABM in tobacco smokers
A further three studies (Attwood et al., 2008; Field et al., 2009; McHugh et
al., 2010) employed the modified visual probe methodology in tobacco smokers.
McHugh et al. (2010) recruited a community sample, while Attwood et al. (2008)
and Field et al. (2009) recruited a predominantly university student sample. Only two
studies found an effect of ABM on AB in the predicted directions (Attwood et al.,
2008; Field et al., 2009). However, there were no reported additional beneficial
effects of ABM in the experimental groups in either study (i.e. no generalisation to
novel stimuli, no reduction in craving or changes in behavioural measures of
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smoking). A similar ‘adverse’ effect in the ‘attend tobacco’ control group to that
found in the studies with alcohol users (see section 3.1.1.1, above) was reported by
Attwood et al. (2008). However, this effect was gender specific, where only men in
this group experienced greater cravings during a smoking exposure test. Such a
gender effect has not been reported since, however, including by Field et al. (2009)
who specifically examined this in their analyses.
All three studies fared well upon critical appraisal (see Table 2), with external
validity being the main issue for Attwood et al. (2008) and Field et al. (2009) given
that their samples were largely drawn from a university student population. While
McHugh et al. (2010) scored well upon appraisal and indeed was sufficiently
powered to detect a significant effect, close examination of the intervention itself
raises possible reasons as to why the authors found no effect of ABM. First, in their
experimental group, probes replaced neutral stimuli on only 85% of trials. While
some studies have chosen to not use a 100% contingency, most studies do not use
below 90%; indeed, both Attwood et al. (2008) and Field et al. (2009) used 100%
contingencies. Second, their probe consisted of a single dot which replaced either the
top image or the bottom image, and participants needed only to indicate its location.
The problem here is that this requires minimal attentional resources, as it is possible
for participants to detect the location of the probe by using their peripheral vision
alone. No other ABM study covered in this review that employed the modified visual
probe paradigm used this probe type, and indeed, all other studies found a significant
effect of ABM on AB at the very least.
3.1.2 Modified Stroop paradigm
One study (Fadardi & Cox, 2009) employed this methodology to modify AB
in a community sample of alcohol users. In relation to substance use, the Stroop task
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consists of substance-related or neutral words presented one at a time, which appear
in one of a few different coloured fonts. As quickly and accurately as possible,
participants are requested to name the font colour (while ignoring the word). The
difference in reaction time to name the font colours of substance-related and neutral
words is analysed, and participants who are slower to respond on substance-related
items are said to have an AB toward those stimuli.
Fadardi and Cox (2009) modified this classic Stroop interference task and
created the Alcohol Attention-Control Training Program (AACTP). Rather than
words, the task uses images of alcoholic and soft drinks, and runs in three
progressively more difficult series. In series one and two, images are displayed
individually with a coloured background (series one) or coloured outline (series two),
and participants are required to name the colour of the outline/background as quickly
as possible. In the third series, an alcoholic and soft-drink stimulus are presented side
by side, each with a coloured outline, and participants must determine the colour of
the outline of the soft-drink stimulus (for full details of the task, see Fadardi and Cox,
2009). In addition, although the AACTP addresses an implicit cognitive process
(AB), it is explicit in its aim, with its rationale explained to participants and feedback
on performance provided (with a view to enhancing participants' motivation).
For the training component of the study, the sample consisted of 68
hazardous drinkers (19 male, mean alcohol consumption = 47.91 (SD = 33.00) UK
units per week; 49 female, mean alcohol consumption = 41.38 (SD = 27.67) UK
units per week) and 92 harmful drinkers (80 male, mean alcohol consumption =
59.70 (SD = 42.48) UK units per week; 12 female, mean alcohol consumption =
83.33 (SD = 48.90) UK units per week) recruited from a university and community
population. The study assessed the AACTP's effect on AB (both groups), as well as
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on actual alcohol consumption (harmful drinkers only). The authors reported a good
outcome, with the AACTP successfully reducing AB for alcohol in both groups, and
with the harmful drinkers also showing reductions in alcohol consumption
(maintained at 3-month follow-up) and improvement on other measures (i.e.
motivation to change, drinking-related locus of control, positive affect and situational
confidence). However, while these findings were statistically significant, it is
difficult to determine the true size and meaningfulness of the change in these
outcomes. For example, since alcohol consumption over time is represented only in a
figure and additional, accurate post-training data are not provided, it is difficult to
determine if, for instance, harmful drinking participants’ alcohol consumption
changed to the extent that they could be reclassified as hazardous drinkers (a
clinically less harmful level of drinking (DH, 2005)).
However, as can be seen in Table 2, the study fared poorly upon critical
appraisal. In particular, it scored poorly on the subscales of confounding and bias.
The major methodological issue was that the study did not include a control group.
Instead, harmful drinking participants acted as their own controls, by waiting one
month before beginning the intervention. While it was indeed true that the
participants in the harmful drinking sample did not change on key measures during
the waiting period, caution must be used when interpreting the results. In addition,
drop-out rates were very high in the harmful drinking group (45.7% by follow-up),
yet this was not accounted for in the data analysis by, for example, the use of an
intention to treat analysis.
Hazardous drinkers also had no control group. This group were given two
sessions of training, one week apart, and their AB was measured before the first and
after the second training sessions. With this design, it is unclear whether two sessions
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of training were necessary to modify AB since there was no assessment of AB at any
time point between training sessions i.e. the effects of training may have worn off
within a week, but the second training session led to a change in AB at the final
assessment.
In addition, it was not clear exactly what data were included in main analyses.
For example, under the analyses for hazardous drinkers (who should drink, on
average, between 22-50 units/week for men or 15-35 units/week for women; DH,
2005), the mean number of units of alcohol consumed for the "high" alcohol
consumption subgroup was quoted as 75.75 (SD = 20.35) units, which is well in
excess of the upper limit for this group. The opposite problem was evident in
analyses for harmful drinkers' data, where the "low" alcohol subgroup consumed on
average just 14.30 (SD = 3.35) units per week (which is within safe limits).
A further methodological issue comes with the use of the Stroop task itself.
There is recent evidence to suggest that factors other than attentional bias can cause
interference on the task, such as the words eliciting subjective craving which in turn
increases cognitive load and therefore leads to interference (Tiffany, 1990), a general
slowing of responding when emotionally salient stimuli are presented (Algom,
Chajut & Lev, 2004), or by participants' attempts to suppress their distraction by
substance-related stimuli (Klein, 2007). It is therefore difficult to infer causality from
studies that employ this methodology.
Taken together, the methodological problems and lack of clarity in reporting
of data means it is difficult to reliably ascertain the effects of the AACTP without
further, more stringent, research.
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3.2 Implicit attitudes
Two studies (Houben, Havermans & Wiers, 2010; Houben, Schoenmakers &
Wiers, 2010) targeted implicit attitudes. Implicit attitudes can be defined as
unconscious or automatic affective associations. It is held that these positive implicit
attitudes develop primarily through classical conditioning principles, where a
substance-related stimulus is repeatedly paired with positive affect (e.g. Olson &
Fazio, 2001). The two studies under review here employed evaluative conditioning
(EC) which rests on the same classical conditioning principles, whereby its aim is to
repeatedly pair substance-related stimuli with negative affect so as to modify the
attitude the individual holds. To use an example of alcohol, in order to modify
implicit attitudes to make them more negative towards alcohol, participants would
see alcohol-related words (e.g. “wine”, “beer”) paired consistently with pictures of
negative facial expressions. In control conditions, alcohol-related words would be
paired consistently with pictures of neutral facial expressions.
Both studies tested relatively large samples of students who drink alcohol
(see Table 1), with Houben, Schoenmakers and Wiers (2010) recruiting males only
(who consumed 24.6 (SD = 2.49) UK units per week on average at baseline), and
Houben, Havermans and Wiers (2010) recruiting a mixed sample, although it was
predominantly (76%) female (who consumed 13.1 (SD = 14.59) UK units per week
on average at baseline). Both studies reported positive outcomes, with participants in
experimental conditions showing more negative attitudes towards alcohol following
EC (an effect was found on implicit attitudes in Houben, Havermans & Wiers
(2010), and explicit attitudes in Houben, Schoenmakers & Wiers (2010)), and
consuming less alcohol at one week follow-up (both studies). In addition, Houben,
Schoenmakers and Wiers (2010) also reported that participants in the experimental
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group reported fewer cravings for alcohol and consumed significantly less alcohol
during a taste test (87.31ml (SD = 56.59) consumed in the experimental condition
versus 118.43ml (SD = 56.55) in the control condition).
The two studies differed in their methodology and design, each with its own
strengths and weaknesses. As can be seen in Table 2, both studies had weaknesses,
particularly with confounding and external validity. The results of both studies are
difficult to generalise given their selective samples of students with clear gender bias.
Houben, Schoenmakers and Wiers (2010) used a covert design, where steps were
taken to conceal the aims of the study from participants. While this was successful
(participants remained unaware of the aims of the study), it prevented the
measurement of attitudes at baseline. Therefore, while differences in explicit
attitudes were reported after EC, it is not known whether there were baseline
differences between groups in these attitudes which might explain this finding.
Houben, Havermans and Wiers (2010) successfully captured key variables at
baseline. However, testing of participants was conducted via the internet, raising
possible questions of the participants’ motivation and effort during testing. While the
authors cited a prior study validating the use of web-based administration of similar
tests (Houben & Wiers, 2008a), this study did not validate the use EC paradigms
online, and at some stage in that cited study all participants met with the researchers
in person, which was not the case in the study under review here. A final weakness
of the Houben, Havermans and Wiers (2010) study, as the authors acknowledge and
discuss, is that there were significant baseline differences between groups in alcohol
consumption and in implicit and explicit attitudes. Taken together, these weaknesses
make meaningful interpretation of the findings extremely difficult.
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3.3 Approach bias
Two studies (Wiers, Eberl, Rinck, Becker & Lindenmeyer, 2011; Wiers,
Rinck, Kordts, Houben & Strack, 2010) targeted approach bias. Approach bias is
characterised as an action tendency, which can be triggered by substance-related
stimuli in substance users. The two studies targeted approach bias in alcohol users,
and both utilised the alcohol Approach Avoidance Task (aAAT). In this task, images
of either alcohol-related or soft-drink stimuli appear in either landscape or portrait
orientation, and participants were instructed to pull a joystick (approach movement)
to one orientation, and push a joystick (avoidance movement) to the other
orientation. Pulling the joystick increases the size of the picture, and pushing
decreases it, therefore simulating the effects of actual physical approach and
avoidance. To assess approach bias, alcohol-related and neutral images appeared
equally often in both orientations, and differences in reaction times across stimuli
and approach/avoidance movements are analysed to establish any approach bias
towards alcohol.
The two studies employed slightly different versions of the training task, so
interested readers are pointed to each paper for a detailed description. In brief, both
studies implicitly trained some participants to avoid alcohol by displaying alcohol-
related images in the orientation requiring an avoidance movement. Wiers et al.
(2011), who also investigated the role of contingency awareness, had another training
version of the task where all images were presented in a square format, but where
participants were instructed to 'avoid' alcohol-related images, and 'approach' soft-
drink related images.
Both studies reported positive outcomes. Wiers et al. (2010), who studied 42
male, hazardous drinking students (mean weekly alcohol consumption: ‘approach’
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group = 25.5 (SD = 9.8) UK units; ‘avoid’ group = 31.9 (SD = 10.4) UK units),
found that a single session the aAAT successfully modified approach bias (with the
biggest effect in the avoid-alcohol group), which generalised to novel stimuli as well
as a different test assessing automatic action tendencies (the Implicit Association
Test (IAT)). Furthermore, in individuals who responded to the training intervention,
there was a significant effect on a taste test, whereby participants in the avoid-
alcohol group consumed significantly less alcohol (approximately 200ml less, SD not
given) than those in the approach-alcohol group. Wiers et al. (2011) found similar
results in their clinical sample of 214 alcoholic inpatients (currently abstinent for 3
weeks following detoxification, but with an approximate duration of alcohol
dependence to that point of 12 years), with four sessions of the aAAT delivered over
four days successfully changing patients' approach bias for alcohol into an avoidance
bias, which again generalised to novel stimuli and to the IAT. Patients in the avoid
alcohol group also tended to have improved treatment outcomes at one-year follow-
up, although this finding was not quite statistically significant. Of note, very few
participants became aware of the contingency in the Wiers et al. (2010) study yet the
intervention was still beneficial. Furthermore, as described above, while Wiers et al.
(2011) designed their study to explicitly examine the role of awareness, the groups
were collapsed for statistical analysis as it was found that awareness of the
contingency had no significant effect on outcome measures.
As can be seen in Table 2, both studies scored highly upon systematic
appraisal. In general, both studies were well-designed and clearly reported. It is
difficult to generalise the results of Wiers et al. (2010) beyond its own sample,
however, as the sample size was quite small and consisted entirely of male university
students. Furthermore, some group differences were evident at baseline, although
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these were controlled for appropriately during statistical analysis. The significant
findings of Wiers et al. (2011), however, provide some reassurance over the findings
of the earlier paper.
4. Discussion
This review has covered studies which aimed to modify implicit processes
that are known to be important in substance use and examined whether such
approaches are effective in eliciting significant change in clinically relevant indices.
Twelve such studies met the criteria for inclusion. Nine studies involved alcohol
users, three involved tobacco smokers, and three different interventions were used
across the studies: attentional bias modification (ABM), evaluative conditioning
(EC) and the alcohol Approach Avoidance Test (aAAT).
The findings across the studies were varied. However, a consistent finding
was that any attempt to modify a specific implicit process was successful in that it
produced significant change in that implicit process. The only exception to this
finding was McHugh et al. (2010), who used a modified visual probe task to alter AB
in tobacco smokers. As discussed above, however, the variation in the specifications
of the ABM task used in their study compared to those used in other similar studies
likely explains its null findings.
Broader conclusions about the potential benefits of these interventions are
precluded, however, as the results were variable both between and within studies
addressing different implicit processes.
Studies investigating community samples have produced mixed results.
Those addressing AB found no benefits of ABM aimed at avoiding substance-related
stimuli beyond the modification of AB itself. There were, however, some additional
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effects of ABM in control participants who were trained to attend to substance-
related stimuli. In these groups, ABM led to an increased urge to drink (Field &
Eastwood, 2005; Field et al., 2007), increased alcohol consumption during a taste test
(Field & Eastwood, 2005), and increased cravings for tobacco during a smoking
exposure task (Attwood et al., 2008). In fact, only one study with an 'attend
substance' control group found no such additional effects (Field et al., 2009). While
these additional effects of ABM in control groups are interesting from a theoretical
point of view, they offer little to the development of treatment approaches for
substance using individuals.
Encouragingly, however, findings from studies addressing other implicit
processes in community samples, while fewer in number, successfully produced
more clinically meaningful results in their experimental 'avoid substance' groups. EC
paradigms brought about decreased alcohol consumption at follow-up (Houben,
Havermans & Wiers, 2010; Houben, Schoenmakers & Wiers, 2010). In addition,
Houben, Schoenmakers and Wiers (2010) also found that EC led to decreased
craving for – and consumption of – alcohol during a taste test. While important,
further studies will be required to replicate these findings, largely due to
methodological issues with each study (see section 3.2. above for details). In
addition, Wiers et al. (2010), who used the aAAT in a study with fewer
methodological and design problems (see Table 2 and section 3.3), also found that
the experimental 'avoid substance' training brought about benefit beyond a change in
approach bias alone, with effects generalising to novel stimuli (a finding only
sometimes reported in studies targeting AB), and participants consuming
significantly less alcohol during a taste test (although this only applied to participants
who responded to training).
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The two studies targeting clinical samples, although few in number, produced
some promising results. Schoenmakers and colleagues (2010), for example, was the
only ABM study using a modified visual probe task to provide evidence of beneficial
effects beyond modification of AB, with their 'avoid substance' experimental group
demonstrating generalisation of ABM effects to novel stimuli and a possible
beneficial influence on treatment outcomes. In addition, Wiers et al. (2011) reported
similarly promising findings with use of the aAAT, although this intervention's effect
on treatment outcomes was at trend-level only. Furthermore, harmful drinkers in
Fadardi and Cox's (2009) sample showed good outcomes, with a decrease in alcohol
consumption and improvement on other secondary measures. However, the findings
from this latter study must be considered in the context of its methodological issues
(see section 3.1.2 above).
4.1 Differential effects in different populations?
Taken together, it is possible to hypothesise differential effects of
interventions targeting implicit processes in different populations. For instance, such
interventions may serve a protective function against repeated exposure to substance-
related stimuli in non-clinical populations consuming relatively lower amounts of
alcohol and tobacco. Houben, Havermans and Wiers (2010) discuss this with respect
to their findings with evaluative conditioning (EC); it was noted that the significant
difference between groups in explicit attitudes following EC was due to the control
group becoming less negative in their attitudes towards alcohol, rather than the
experimental group becoming more negative. They suggest that EC may therefore
have acted as a buffer against the negative effects of repeated exposure to alcohol-
related stimuli. It should be noted that approaches using the aAAT demonstrate early
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promise in providing benefit beyond a change in approach bias alone in non-clinical
populations (Wiers et al., 2010), although replication is necessary to ensure these
findings are reliable and to establish whether such effects continue across a follow-
up period.
On the other hand, in studies examining clinical samples, more clinically
desirable effects are observed following interventions aimed at reducing implicit
biases. Given that implicit biases are positively correlated with the degree of
substance use (e.g. AB in alcohol use: Townshend & Duka, 2001; AB in heroin use:
Bearre, Sturt, Bruce & Jones, 2007; AB in cannabis use: Field, 2005; implicit
attitudes in alcohol use: Houben & Wiers, 2008b), it may be the case that these
biases are more amenable to modification in clinical samples, and also that effects
beyond change in implicit biases alone are more detectable given that scores on
commonly measured outcomes in such studies are significantly higher at baseline in
clinical groups seeking treatment (e.g. craving is higher, substance use is higher).
However, the studies examining clinical populations also employed multiple
training sessions of the implicit intervention. It is therefore possible that it is simply
multiple training sessions that is important to achieve broad benefits of training
interventions. Further research is therefore necessary to establish which of these
hypotheses is correct i.e. whether training interventions provide broad benefit in
clinical samples and a protective effect in non-clinical samples, or whether such
interventions require repeated administration to generate wider benefits. Of course,
these possibilities are not necessarily mutually exclusive, and should both be true
then these interventions could be useful as both protective for at-risk individuals and
as a useful adjunct to treatment for clinical populations.
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4.2 Awareness and motivation
A final point of discussion is the role of participants' awareness and
motivation. A goal in much substance misuse treatment is to enhance an individual's
motivation to change prior to beginning treatment (e.g. Motivational Interviewing;
Miller & Rollnick, 2002). However, the role of motivation in the studies reviewed
here has had mixed findings. On the one hand, Fadardi and Cox (2009) built
feedback into their task to motivate participants to improve their performance.
Importantly, while their intervention increased motivation as assessed by the
Readiness To Change Questionnaire (Rollnick, Heather, Gold & Hall, 1992), their
secondary analyses revealed that it was those participants who entered the study
highest in adaptive motivation at baseline (as measured by the Personal Concerns
Inventory (Cox & Clinger, 2002)) had the best outcomes following ABM. On the
other hand, however, Wiers et al. (2011) found no difference in outcome between
participants randomly assigned to either an explicit or implicit training condition i.e.
attempts to inform participants of experimental contingencies and enhance their
motivation made no difference to outcomes. Indeed, most studies reviewed here
attempted to blind participants to the objectives of the research, and most (but not all)
found that participants generally remained unaware of experimental contingencies
and that contingency awareness did not significantly affect the results.
4.3 Summary
In sum, to date, research examining the impact of interventions that target
implicit cognition in substance users show promise in reducing implicit processing
biases and other clinically relevant outcomes. However, studies are few in number,
which means broader conclusions cannot be drawn. Indeed, there have been only two
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studies examining implicit interventions in clinical populations to date, and taken
together the literature has only examined alcohol drinkers and tobacco smokers.
While one might predict on the basis of the underlying theory that similar findings
would be produced with users of other substances, the present findings cannot be
generalised in this way and further research with individuals who use other
substances would be necessary to confirm such a prediction. Indeed, it is likely that
at least some participants in the studies reviewed here also use substances other than
those targeted by the intervention (e.g. some alcohol drinkers are also likely to smoke
tobacco), which therefore makes the picture more complex.
Future research should therefore aim to address the importance of single
versus multiple training sessions, to clarify the importance and impact of participants'
awareness and motivation, and to assess, perhaps by way of longitudinal studies,
whether interventions targeting implicit cognition can have a protective or
preventative effect in non-clinical populations.
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Part 2: Empirical Paper
Attentional bias modification in substitute-prescribed
opiate users and control participants
ATTENTIONAL BIAS MODIFICATION IN OPIATE USERS
48
Abstract
Aims: Attentional bias (AB) is important in the development and maintenance of
substance dependence, with links to craving, frequency of substance use, and
substance misuse treatment outcome. Reducing AB for substance-related stimuli
using AB modification (ABM) may therefore have important clinical benefits for
substance users. This study assessed these potential benefits in an opiate dependent
(patient) sample, with comparison to a non-substance using (control) group. The role
of treatment adherence (i.e. whether or not an individual uses illicit opiates on top of
their prescribed substitute) in patient participants was also examined.
Method: 23 patient and 21 control participants were randomised to receive either an
ABM task designed to train attention away from substance-related stimuli (ABM-as),
or a control task (ABM-n). AB and cravings were assessed immediately before and
30 minutes after ABM-as/ABM-n. AB, craving and frequency of substance use were
also assessed at one-week and one-month follow-up in patient participants.
Results: ABM-as had no significant effect on AB for any of the participants, or on
AB or craving over time in patient participants. However, use on top was an
important factor in patient participants. Patient participants not using on top had a
significantly greater AB away from substance-related stimuli than control
participants, and significantly lower craving, depressive symptomatology, and
impulsivity than patient participants who were using on top.
Discussion: Although the main hypotheses of the study were not supported, the
secondary analyses around treatment adherence revealed some important findings.
Specifically, the data suggested that it may be unhelpful to view opiate dependent
individuals as a homogenous group since, depending on their use on top, they
differed on baseline AB, craving and psychopathology. The clinical and research
implications of these differences are discussed.
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1.0 Introduction
Attentional bias (AB) - where disorder-related stimuli grab one's attention -
has been consistently demonstrated in users of different substances when compared
to non-substance users, including alcohol (e.g. Cox, Blount & Rozak, 2000;
Stormark, Laberg, Nordby & Hugdahl, 2000), tobacco (e.g. Bradley, Field, Mogg &
DeHouwer, 2004; Mogg, Bradley, Field & DeHouwer, 2003), cannabis (Field,
Eastwood, Bradley & Mogg, 2006), cocaine (Copersino et al., 2004; Hester, Dixon &
Garavan, 2006) and heroin (Constantinou et al., 2010; Fadardi & Ziaee, 2010;
Franken, Kroon, Wiers & Jansen, 2000; Lubman, Peters, Mogg, Bradley & Deakin,
2000). Furthermore, AB has long been linked to subjective craving in addiction.
Indeed, this link is supported by a recent meta-analysis which found a significant
(albeit weak) association between AB and craving (Field, Munafò & Franken, 2009).
AB has also been linked to relapse in individuals abstaining from substance
use, including heavy drinkers (Cox, Hogan, Kristian & Race, 2002), tobacco smokers
(Waters et al., 2003), heroin users (Marissen et al., 2006) and cocaine users
(Carpenter, Schreiber, Church & McDowell, 2006). Constantinou et al. (2010) also
found that AB away from substance-related stimuli was positively correlated with
length of abstinence in ex-heroin users, suggesting a link between AB and treatment
progress. The results of these studies therefore suggest that AB can be either a risk
factor for relapse (increased AB), or a promoter of abstinence (decreased AB).
Such findings have understandably led to the inclusion of AB in many recent
theoretical models of addiction (e.g. Field, 2006; Franken, 2003; Ryan, 2002), where
AB is awarded a central role in both the development and maintenance of substance
use. Within these models, subjective craving and AB are interrelated phenomena,
which form a positive feedback loop (i.e. there is a causal relationship between the
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two), leading to increased substance use. Evidence of this causal mechanism to date
seems to support this (see Field & Cox, 2008, for a review; see also Volume 1, Part 1
of this thesis). It follows, therefore, that direct manipulation of AB ought to produce
meaningful changes in subjective craving, which could in turn impact on substance
use behaviour.
To date, the most methodologically rigorous approach to addressing this
question has been with the use of the modified visual probe task, which aims to
experimentally manipulate AB (see MacLeod, Rutherford, Campbell, Ebsworthy &
Holker, 2002, for a description). In the context of substance use, the task involves the
presentation of two images on a computer screen: one substance-related image, and a
matched neutral image. The images are followed by a probe – which may be, for
example, an upwards or downwards arrow – which appears in the location of one of
the images, and participants must identify the probe type as quickly and accurately as
possible by pressing one of two response keys. In the standard version of the visual
probe task, which measures AB, probes replace substance-related and neutral images
equally often. AB is then determined by comparing reaction times to the probe when
it replaced the substance-related images versus the neutral images. AB for substances
is found where participants are significantly faster to respond to the probe when it
replaces the substance-related images. In the modified version of the task, where AB
is trained (hereafter referred to as AB modification; ABM), the contingency of probe
location is adjusted so that the probe replaces one type of image more often than the
other. For example, to train attention away from substances, one would always
replace the neutral images with probes, so that in order to improve at the task and
become faster at responding, participants should direct their attention toward the
neutral stimuli, rather than the substance-related stimuli.
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To date, the modified visual probe paradigm has been applied to tobacco
smokers (Attwood, O'Sullivan, Leonards, Mackintosh & Munafò, 2008; Field, Duka,
Tyler & Schoenmakers, 2009; McHugh, Murray, Hearon, Calkins & Otto, 2010), and
to alcohol users in both community samples (Field & Eastwood, 2005; Field et al.,
2007; Schoenmakers, Wiers, Jones, Bruce & Jansen, 2007) and a clinical sample
(Schoenmakers et al., 2010).
All but one of these studies reported significant effects of ABM in the
predicted direction on AB itself. McHugh and colleagues (2010) were the only
researchers to report no effect of ABM. However, close examination of the
specifications of their ABM task reveals a likely explanation for this; given that
participants were required to respond to the location of probe only, their task was
therefore less demanding of participants and could be completed by using peripheral
vision alone. Typical ABM research requires participants to discriminate between
two probe types, making the task more demanding and thus more likely to produce
an effect on AB. It is therefore reasonable to assume that, on balance, ABM is
successful in altering AB in tobacco and alcohol users.
Mixed findings have been reported, however, for the broader effects of ABM
on subjective craving and substance use behaviour. Some studies noted ‘adverse’
effects of ABM towards substances, where such interventions increased subjective
craving (Attwood et al., 2008, although in male participants only; Field & Eastwood,
2005; Field et al., 2007, although for participants aware of experimental
contingencies only). Field and Eastwood (2005) further reported that participants in
their ‘attend alcohol’ ABM group consumed more alcohol during a laboratory based
taste test. However, in the clinically relevant ‘avoid substance’ training conditions,
there have been limited reports of broader beneficial effects of ABM beyond a
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change in AB itself. Indeed, only one study found such additional effects
(Schoenmakers et al., 2010). In their clinical sample, Schoenmakers and colleagues
found that while ABM did not have an immediate effect on subjective craving,
training generalised to novel stimuli and participants in the ‘avoid alcohol’ group
were also discharged from treatment significantly earlier than participants in the
control group.
The extent to which ABM generalises to novel stimuli is also unclear on the
basis of the research to date. As mentioned above, generalisation has been reported
by some authors (i.e. Field et al., 2007, although in the ‘attend alcohol’ group only;
Schoenmakers et al., 2010). However, other studies that have specifically
investigated the question of generalisation have reported no such effect (Field et al.,
2009; Schoenmakers et al., 2007).
In sum, AB has a central role in the development and maintenance of
addiction, as evidenced by its relationship with subjective craving and its prediction
of relapse. However, while the experimental manipulation of AB has produced some
support for a causal relationship between AB, craving and substance use (as
evidenced by increases in craving and substance use following ABM towards
substance-related stimuli), evidence for its clinical utility is more limited, with
evidence of generalisation being equivocal, and with just one study reporting
clinically relevant, broader effects of ABM away from substances.
Noteworthy, however, is the fact that the one study that did report benefits of
ABM away from substances was the only study to recruit a clinical sample of
substance dependent, treatment-seeking patients (alcohol users; Schoenmakers et al.,
2010). Given that AB is positively correlated with frequency of substance use (e.g.
Bearre, Sturt, Bruce & Jones, 2007; Field, 2005; Townshend & Duka, 2001), it may
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be the case that AB is more amenable to modification in clinical samples. Further,
effects beyond change in AB alone are also more detectable given that scores on
commonly measured outcomes (e.g. craving and substance use) are significantly
higher at baseline in clinical populations. It is therefore possible that ABM may
produce broader, clinically relevant effects in clinical populations, while in non-
clinical populations (with weaker AB) it serves as a protective factor against
exposure to substance-related stimuli. However, it should also be noted that
Schoenmakers et al. (2010) was also the only study to employ multiple sessions of
ABM. This therefore raises the possibility that it is simply multiple training sessions
that is important to achieve broader benefits of ABM.
The current study aimed to extend the research in this area, investigating AB
in an opiate dependent, clinical sample. As described above, four studies have
previously demonstrated significantly greater AB towards substance-related stimuli
in opiate users relative to non-users. Two such studies (Fardardi & Ziaee, 2010;
Franken et al., 2000), however, have employed the Stroop task, and thus are limited
by the problems with interpreting this task (Algom, Chajut & Lev, 2004; Klein,
2007; Tiffany, 1990). Another study (Lubman et al., 2000), while employing the
methodologically more rigorous visual probe task, was limited in that control
participants in that study consisted of staff at a substance misuse service who may
themselves have an AB for substances. Constantinou et al. (2010), however, again
using the visual probe task, provided good quality evidence that AB towards
substance-related stimuli exists in current opiate dependent populations relative not
only to control participants, but also relative to formerly opiate dependent
participants. As described above, also, the authors noted a positive correlation
between AB away from substance-related stimuli and length of abstinence in ex-
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users of heroin. Taken together, this suggests that AB and treatment progress may be
linked. However, no other study has yet addressed this possibility.
To date, modification of AB in opiate users has not been investigated.
Therefore, this study aimed to examine the effects of a single session of ABM on
AB, subjective craving, and frequency of substance use using a modified visual
probe task in opiate dependent participants. Generalisation of ABM to novel stimuli
was also examined. In addition, comparisons were also made to a non-substance
using control group, and opiate dependent participants were followed up at one-week
and one-month following ABM to assess its longer-term effects on craving and
substance use. Specifically, we hypothesised that:
1. Opiate dependent participants would show a significant baseline AB
toward substance-related stimuli relative to non-substance using
participants, who would show no such bias.
2. A between subjects ABM would produce significant group differences in
AB, with participants receiving ABM away from substance-related
stimuli (the ‘avoid-substance’ ABM group; ABM-as) showing decreased
AB for opiate-related stimuli, whereas participants receiving a standard
visual probe task as a control condition (i.e. the ‘neutral’ ABM group;
ABM-n) would show no significant change in AB.
3. Amongst opiate-dependent participants, relative to the ABM-n group, the
ABM-as group would show a significant decrease in subjective craving
immediately following ABM.
As part of secondary analyses, the questions of generalisation of ABM to
novel stimuli and the role of awareness of experimental contingencies were
addressed. In addition, given that no ABM study using the modified visual probe task
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to date has examined the longer-term effects of ABM on AB itself, craving, or
frequency of substance use, we also explored the effects of this single session of
ABM on these outcomes at one-week and one-month follow-up amongst opiate
dependent participants. Finally, given that the only previous visual probe study with
an adequate control group showed that progress through treatment was an important
independent variable in determining AB (Constantinou et al., 2010), in this study we
also explored this by comparing those participants who adhered to opiate substitute
medication only versus those who, in addition to their prescribed substitute,
continued to use opiates illicitly.
2.0 Method
This was a joint study with a fellow Trainee Clinical Psychologist, Clare
Wellington (see Wellington, 2013), and our sample was therefore shared. Additional
assistance in data collection was provided by Claire Mokrysz, a PhD student at
University College London (UCL). Appendix B sets out the specific contributions of
each person to the study.
2.1 Participants
A priori power analysis was performed (using “G*Power” software; Faul,
Erdfelder, Lang & Buchner, 2007) specifying alpha = 5% and desired power = 80%.
Effect size estimates for the primary analysis (effect of ABM on AB) were based on
Field and Eastwood (2005) and Schoenmakers et al. (2010), who quote effect sizes of
d=1.27 and d=0.87, respectively. Using the latter, smaller effect size statistic, the
power analysis gave a required sample size of 28 participants in total.
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Two independent groups of participants were recruited: 23 current opiate
users (patient group) and 21 non-substance using control participants (control group).
Participants in the patient group were required to be opiate users prescribed a
substitute medication (either methadone or buprenorphine) as part of a treatment
programme at a local National Health Service (NHS) substance misuse service, and
have normal or corrected-to-normal vision. They were recruited via poster
advertisements and/or through their key workers. Exclusion criteria were a current
diagnosis of a psychotic disorder or alcohol dependence. Furthermore, with the
exception of their prescribed substitute, participants were required to be free from the
influence of drugs and alcohol on the days of testing.
Given the relatively high levels of depression and anxiety in opiate using
populations (e.g. Regier et al., 1990; Regier, Rae, Narrow, Kaelber & Schatzberg,
1998), it was originally intended to recruit all control participants from a local NHS
Improving Access to Psychological Therapies (IAPT) service, so that such
symptomatology was similar between the two groups. However, it was necessary to
broaden the range of individuals in the control group to include healthy control
participants. This was in order to address the gender imbalance of patients
comprising substance misuse (majority male) and IAPT (majority female) services so
that our two groups were matched in terms of gender, and also because time
constraints on the research meant that recruiting a sufficient number of male
participants from the IAPT service would not have been possible. The final control
group sample consisted of 10 participants recruited from IAPT, and 11 healthy
control participants.
All participants in the control group were required to have normal or
corrected-to-normal vision. IAPT participants were recruited via poster
ATTENTIONAL BIAS MODIFICATION IN OPIATE USERS
57
advertisements, or from a database of the service’s patients who were interested in
research (this database was maintained by the IAPT service). Healthy control
participants were recruited via UCL Psychology Sona System, an online service
which displays study advertisements and facilitates the recruitment of members of
the local community for research. Exclusion criteria for the control group were
current illicit substance use, alcohol dependence or psychotic disorder, and a history
of substance abuse or dependence, or alcohol dependence.
Prior to participation, all participants were required to read the relevant
Participant Information Sheet (see Appendices C, D and E for the Participant
Information Sheets for patient and control group participants), and written, informed
consent was also obtained from all participants (see Appendices F, G and H for
copies of the consent forms for the patient and control groups). Participants were
compensated for their time; due to differences in time commitment from participants
in each group (see section 2.5, below), participants in the patient and control groups
were reimbursed £20 and £10, respectively. Ethical approval for this study was
obtained from the NHS National Research Ethics Service Committee South East
Coast – Surrey (reference number 12/LO/1075; see Appendix I), and from UCL
Division of Psychology and Language Sciences Ethics Committee (reference number
CEHP/2013/503; see Appendix J).
2.2 Overview of experimental design
A mixed experimental design was employed. Between subjects factors were
participant group (patient or control group) and attentional training group (ABM-as
or ABM-n). Dependent variables in the study were AB, subjective craving and
substance use. With the exception of frequency of substance use, all dependent
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variables were measured at four time points (before ABM, 30 minutes following
ABM, and at one-week and one-month follow-up). For most analyses, time was
therefore the primary within subjects factor.
2.3 Questionnaire measures
2.3.1 Depression and anxiety
Baseline levels of depressive and anxious symptomatology were assessed
using the Patient Health Questionnaire-9 (PHQ-9, range of possible scores from 0-
27; Kroenke, Spitzer & Williams, 2001) and Generalized Anxiety Disorder-7 (GAD-
7, range of possible scores from 0-21; Spitzer, Kroenke, Williams & Löwe, 2006),
which are both routine outcome measures used across IAPT services in England.
Assessment of depressive symptoms was further supplemented by the use of the
Beck Depression Inventory-II (BDI-II, range of possible scores from 0-63; Beck,
Steer & Brown, 1996). All three questionnaires are self-report measures assessing
symptomatology occurring in the past two weeks, with higher scores representing
greater levels of symptomatology.
2.3.2 Impulsivity
Trait impulsivity was assessed using the Barratt Impulsiveness Scale-11
(BIS-11; Patton, Stanford & Barratt, 1995; see Appendix K), which is a 30-item,
self-report questionnaire with a possible range of scores from 30-120, with higher
scores indicating greater levels of impulsivity.
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2.3.3 Substance use
A 28-day substance use history was taken by means of interview. Participants
were asked the following:
1. Which substances they used (including alcohol and tobacco; control group
participants were excluded if they currently used substances other than
alcohol or tobacco).
2. The amount they typically used on any given occasion (including the
approximate cost).
3. When they last used each of these substances.
4. To estimate their usage over the previous week.
5. To work backwards and to estimate their usage over the three weeks prior to
their usage in the previous week.
2.3.4 Subjective craving
Subjective craving was assessed by a three-item Visual Analogue Scale
(VAS; see Appendix L). The items were: “I would like to use drugs,” “I want to use
drugs,” and “I have an urge to use drugs”, each with “Not at all” and “Extremely” as
their anchors. Participants were instructed to draw a vertical line that bisected the 10
centimetre horizontal scale to reflect how they felt at that particular moment in time.
Low scores on this scale reflected low craving.
2.4 Attentional bias tasks
The specifications of all AB tasks are described in detail below. For
reference, a summary of the tasks including which stimuli are used in each, number
of trials etc. is available in Table 1.
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2.4.1 Stimuli
The stimuli used were 44 picture pairs. Forty pairs – each matched for visual
complexity and composition – contained one opiate-related image and one non-
opiate related (neutral) image; the remaining four pairs contained neutral images
only. The 40 opiate-neutral pairs were divided into five sets of eight (Sets 1-5),
which were used at different stages of AB assessment and ABM. While many
characteristics of the AB tasks were counterbalanced, the stimuli were not i.e. the
stimuli used in each task (as described below and in Table 1) applied to all
participants in the study. Examples of image pairs can be found in Figure 1.
Table 1
Summary of AB task specifications
Task % trials probe
replaces neutral
image
Stimuli used (number of
presentations of each pair)
Total number of trials
AB-0 50 Set 1 (8)
2 neutral pairs (8)
80
(64 critical, 16 neutral)
ABM-as 100 Sets 1-4 (16) 512 critical
ABM-n 50 Sets 1-4 (16) 512 critical
AB-1, AB-2,
AB-3
50 Set 1 and 5 (8)
4 neutral pairs (8)
160a
(128 critical, 32 neutral)
a Given the use of Set 1 and Set 5, 50% of critical and neutral trials assessed familiar stimuli (Set 1 and
two neutral pairs from AB-0) and 50% assessed novel stimuli (Set 5 and two previously unseen
neutral pairs).
2.4.2 Assessment of attentional bias
Assessment of AB took place on four separate occasions during the study:
immediately before ABM (on Day 1), 30 minutes after ABM (on Day 1), and at one-
week (Day 2) and one-month (Day 3) follow-up (see section 2.5, below for an
explanation of terminology). Assessment of AB was achieved using a standard visual
probe task.
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Figure 1: Examples of opiate-neutral (top two rows) and neutral-neutral
(bottom row) picture pair stimuli used in the visual probe tasks.
The format of a single trial of the visual probe task is displayed in Figure 2.
Each trial began with a fixation point (displayed for 500ms). A pair of images then
appeared: one image to the left of the fixation point, the other to the right. Images
appeared for either a short (200ms) or long (500ms) duration assessing automatic
orienting, and controlled processing of attention, respectively. Image pairs were then
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replaced by a probe –
in the location of either
screen until a response was recorded. For tasks assessing
opiate-related and neutral images equally often. The position of the opiate
image, probe location, and stimulus duration were all counterbalanced, and an equal
number of each probe type was presented. Participants were required to respond by
indicating the direction of the arrow by pressing one of two response keys on a
keyboard (‘k’ for upwards, ‘m’ for downwards)
possible. The inter-trial interval was a randomly determined duration between 250
500ms.
either an arrow pointing upwards or downwards
the neutral or substance-related image, and remained on
AB, the probes replaced the
as quickly and accurately as
Figure 2: A visual representation of
modified visual probe
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– which was
-related
-
a single trial of the
task.
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2.4.2.1 Baseline assessment of attentional bias
Baseline assessment of AB (AB-0) took place on Day 1. The stimuli for this
task consisted of Set 1 of the opiate-neutral pairs, plus two neutral-neutral pairs.
Trials were displayed in a single block, with each pair presented eight times,
producing 64 critical trials and 16 neutral trials (80 trials in total). Trials were
displayed in a new random order for each participant.
2.4.2.2 Follow-up assessment of attentional bias
Follow-up assessment of AB took place after 30 minutes of ABM on Day1
(AB-1), and again on Day 2 (AB-2) and Day 3 (AB-3). Stimuli from Sets 1 and 5
were used, together with all four neutral-neutral image pairs, thus allowing the
assessment of the effects of ABM on both familiar (Set 1 and two neutral pairs from
AB-0) and novel (Set 5 and two unseen neutral pairs) stimuli. Each pair was
presented eight times, giving 128 critical (64 familiar, and 64 novel) and 32 neutral
(16 familiar, 16 novel) trials. Stimuli were presented in a single block and displayed
in a new random order for each participant.
2.4.3 Attentional bias modification
ABM took place on Day 1, immediately following the completion of AB-0.
Stimuli consisted of Sets 1-4 of the opiate-neutral pairs. No neutral-neutral pairs
were used. Each pair was presented 16 times, producing 512 critical trials. Stimuli
were presented in two blocks of 256 trials each, with participants given a short break
between blocks. For participants randomised to the ABM-as group, probes replaced
neutral images on 100% of trials. For participants randomised to the ABM-n group,
the probe was located behind neutral images on 50% of trials, and was
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counterbalanced in the same manner as the assessment of AB tasks (see section
2.4.2, above).
2.4.4 Contingency awareness
Participants’ awareness of experimental contingencies was assessed in two
ways. First, participants were asked for their ideas about the purpose and aim of the
study. Second, they were asked specifically whether or not they detected any patterns
in the ABM task with respect to the probe location. Participants were deemed aware
of the experimental contingency if either they correctly described the aim of the
study or the pattern in probe location.
2.5 Procedure
An overview of the study procedure can be found in Figure 3. The study
comprised three separate testing sessions. The first and second sessions (Days 1 and
2) took place exactly 7 days apart, and the third session (Day 3) three weeks later.
Given that our control participants should not exhibit an AB towards substance-
related stimuli and were not substance users, they were only required to attend Day 1
of testing. Day 1 took approximately 90 minutes to complete. Days 2 and 3 took
approximately 15 and 20 minutes, respectively.
On Day 1, participants were screened by semi-structured interview for their
eligibility to participate based on the criteria outlined in section 2.1, above. Eligible
participants who consented to participate were then randomly assigned to either the
ABM-as or ABM-n training condition, and all participants completed baseline
measures (PHQ-9, GAD-7, BDI-II, 28-day substance use history, BIS-11, VAS).
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Day 1 All
participants
Screening and randomisation
PHQ-9, GAD-7, BDI-II, 28-day substance history, BIS-11, VAS
Assessment of AB (AB-0)
Modified visual probe task (ABM-as) OR standard visual probe task
(ABM-n)a
VAS
30-minute break
Assessment of AB (AB-1)
VAS
[Control group only: contingency awareness questions & debrief]
Day 2 Patient group
only
PHQ-9, GAD-7, BDI-II, VAS
Assessment of AB (AB-2)
Day 3 Patient group
only
PHQ-9, GAD-7, BDI-II, 28-day substance history, VAS
Assessment of AB (AB-3)
Contingency awareness questions & debrief
Figure 3: Overview of the experimental procedure
a Participants randomised to the 'avoid-substance’ group completed ABM-as, whereas participants
randomised to the ‘neutral’ group completed ABM-n.
Participants next completed AB-0, followed immediately by ABM-as or
ABM-n, dependent on randomisation.
Following this, participants had a break of approximately 30 minutes. During
this time they completed two unrelated tasks pertaining to a separate study (see
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Wellington, 2013). AB-1 and a VAS were then administered again to re-assess AB
and subjective craving, respectively.
Control participants’ awareness of the experimental contingencies was
assessed at the end of this testing session, and they were then debriefed and paid for
their participation.
Only participants in the patient group attended Day 2 and Day 3. On these
days, AB-2 and AB-3 was administered, respectively, as was the PHQ-9, GAD-7,
BDI-II and VAS. A further 28-day substance use history was also taken on Day 3. At
the end of Day 3, participants’ awareness of experimental contingencies was
assessed, participants were paid for their time and a full debrief was provided.
2.6 Data analysis
2.6.1 Attrition
Of the 23 participants in the patient group, only data from one participant
were missing at one-week follow-up due to their non-attendance for testing. Full data
were available from the remaining 22 participants (96% overall retention). Full data
were available from all participants in the control group.
In addition, due to an administration error, craving data from one participant
in the patient group assigned to ABM-n were unavailable following the 30-minute
delay on Day 1 of testing.
2.6.2 Preparation of data
Checks of normality of all the data revealed that all variables were normally
distributed, and there were no significant outliers (≥3 SDs) on key variables that
warranted removal. With respect to the visual probe data, any trials where a response
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error was made were excluded. Furthermore, to eliminate outliers, any trials where
reaction time (RT) was less than 200ms (implausibly fast), or greater than 2000ms
(likely reflecting lapses in concentration) were also excluded (c.f. Schoenmakers et
al., 2007; Schoenmakers et al., 2010). All trials where neutral-neutral stimulus pairs
were presented were removed for the purpose of analysis. Within opiate-neutral
stimulus pairs, attentional bias scores were calculated by subtracting RTs to probes
that replaced opiate-related stimuli from RTs to probes that replaced neutral stimuli.
A positive AB score therefore indicated AB towards opiate-related stimuli. Given
that RT data were normally distributed, mean RTs were used in analyses pertaining
to AB tasks (c.f. Attwood et al., 2008; Field & Eastwood, 2005; Field et al., 2007;
Field et al., 2009). Repeating these analyses using median data did not significantly
change the results reported below.
3.0 Results
3.1 Participant characteristics
Table 2 displays summary demographic and baseline data for the participants
in each group. Groups were compared on each variable using one-way ANOVAs,
and post-hoc Bonferroni adjusted comparisons were conducted across all groups to
identify significant group differences.
At baseline, there were significant differences in years of education [F(3, 40)
= 6.68, p = .001], VAS ‘like’ [F(3, 40) = 4.83, p = .006], VAS ‘want’ [F(3, 40) =
5.26, p = .004], VAS ‘urge’ [F(3, 40) = 6.09, p = .002], BDI-II [F(3, 40) = 4.56, p =
.008], and PHQ-9 [F(3, 40) = 5.52, p = .003]. Post-hoc analyses revealed that control
participants allocated to ABM-n had significantly more years of education than both
patient participants allocated to ABM-as (p = .001) and to ABM-n (p = .014), VAS
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‘like’, VAS ‘want’ and VAS ‘urge’ was significantly greater in the patient
participants allocated to ABM-n than both control participants allocated to ABM-as
(like: p = .015; want: p = .006; urge: p = .003) and ABM-n (like: p = .019; want: p =
.022; urge: p = .006). Further, the difference in BDI-II was driven by patient
participants allocated to ABM-as scoring significantly higher than control
participants allocated to ABM-n (p = .040), and the difference in PHQ-9 was driven
by patient participants allocated to ABM-n scoring higher than control participants
allocated to ABM-n (p = .004).
Table 2
Mean (SD) of demographic and baseline variables for each group
Patient group Control group
ABM-as
(n=11)
ABM-n
(n=12)
ABM-as
(n=11)
ABM-n
(n=10) p
a
Age 43.91 (6.77) 45.17 (8.89) 41.00 (8.53) 38 (6.68)
Gender (M:F) 10:1 10: 2 8:3 7:3
Years of education 11.91 (1.64) 13.33 (2.81) 14.00 (4.02) 17.30 (2.32) **
Methadone dose 62.75 (25.78) 60.56 (36.70) - -
Buprenorphine dose 9.33 (2.31) 7.33 (7.57) - -
Opiate useb 4 8 - -
BDI-II 22.7 (13.9) 21.8 (10.3) 10.6 (13.1) 8.4 (7.0) **
PHQ-9 10.7 (6.3) 13.3 (6.2) 6.4 (7.5) 3.6 (3.7) **
GAD-7 9.1 (7.4) 7.3 (6.1) 4.6 (5.9) 6.3 (3.9)
BIS 66.9 (11.4) 72.9 (19.9) 58.6 (13.5) 59.0 (8.3)
VAS ‘like’ 2.1 (2.3) 3.4 (3.5) 0.4 (0.7) 0.4 (0.7) **
VAS ‘want’ 1.8 (2.0) 3.1 (3.1) 0.1 (0.2) 0.5 (1.0) **
VAS ‘urge’ 1.3 (1.7) 3.3 (3.4) 0.1 (0.2) 0.3 (0.7) **
Note: Mean total scores are displayed for the PHQ-9, BDI-II, GAD-7 and BIS-11 measures; VAS
‘like’: the extent to which a participant ‘would like to use drugs’; VAS ‘want’: the extent to which a
participant ‘wants to use drugs’; VAS ‘urge’: the extent to which a participant ‘has an urge to use
drugs’. See section 2.3 for details of these measures and their interpretation.
a *p<.05, **p<.01, ***p<.001.
b Denotes the number of participants that were using illicit opiates in addition to their prescribed
substitute.
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3.2 AB at baseline
Following preparation of the data obtained from AB-0 (see section 2.6.2), a
total of 94 (3.4%) trials were excluded due to incorrect responses, and a further 56
(2%) due to reaction times being beyond the pre-specified limits.
Patient participants did not differ significantly from control participants on
stimuli displayed for 200ms [t(42) = -0.11, p = .912], but there was a trend at 500ms
[t(42) = -1.92, p = .066] where contrary to prediction, patient participants (M = -
24.53, SD = 83.34) showed a slight bias away from substance-related stimuli relative
to control participants (M = 11.16, SD = 30.91).
3.3 Effects of ABM on AB
3.3.1 Immediate effects for all participants
Only AB scores for familiar stimuli (50% of critical trials) were used from
AB-1. In addition to trials removed from AB-0, 62 (2.3%) trials due to error and a
further 9 (0.3%) due to reaction time were removed from the data available from AB-
1.
AB scores were analysed using a mixed-design 4x2x2 ANOVA, with a
between-subjects factor of group (4 levels: patient ABM-as, patient ABM-n, control
ABM-as, control ABM-n), and two within subjects factors of duration of stimulus
presentation (2 levels: 200ms, 500ms) and time (2 levels: AB-0, AB-1).
The predicted interaction between group and time was non-significant [F(3,
40) = 0.82, p = .491, ߟ௣ଶ = .058]. Furthermore, there were no other significant main
effects or interactions.
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3.3.2 Effects over time for the patient group
Table 3 displays the total number and percentage of trials excluded from each
AB task for the opiate group participants; overall, these were low (~2%).
AB scores were analysed using a mixed-design 2x2x4 ANOVA, with a
between-subjects factor of ABM condition (2 levels: ABM-as, ABM-n), and two
within subjects factors of duration of stimulus presentation (2 levels: 200ms, 500ms)
and time (4 levels: AB-0, AB-1, AB-2, AB-3).
The predicted two-way interaction between ABM condition and time was
non-significant [F(1.708, 34.168) = 0.34, p = .683, ߟ௣ଶ = .017; Greenhouse-Geisser
adjusted]. In addition, there were no other significant main effects or interactions.
Table 3
Total number and percentage of trials excluded due to incorrect response or reaction
times beyond the pre-specified limits
Errors Reaction time beyond pre-specified
limits
n trials removed % trials removed n trials removed % trials removed
AB-0 55 3.7 49 3.3
AB-1 40 2.7 2 0.1
AB-2 51 3.6 3 0.2
AB-3 47 3.2 0 0
Note: data displayed for AB-1, AB-2 and AB-3 represent data for trials with familiar stimuli only.
3.4 Effects of ABM on craving for patient group on Day 1
Craving data for VAS ‘like’, ‘want’ and ‘urge’ were analysed separately
using a mixed-design 2x3 ANOVA, with a between-subjects factor of ABM
condition (2 levels: ABM-as, ABM-n), and a within-subjects factor of time (3 levels:
pre-ABM, post-ABM, after 30-minute delay).
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The predicted interaction between ABM condition and time was non-
significant for any VAS subscale (all ps > .400), as were all other main effects and
interactions.
3.5 Other main analyses
Given there were no significant effects of ABM on AB or craving measures,
secondary analyses on generalisation of ABM to novel stimuli, and cravings and
frequency of substance use at follow-up were not conducted. In addition, only one
control participant allocated to ABM-as correctly identified the contingency in the
ABM task and so no analyses on the role of contingency awareness were conducted.
3.6 Secondary analysis: the role of treatment adherence
Given the tendency for an AB away from opiate-related stimuli in patient
participants relative to control participants, which was found previously to be found
associated with treatment variables (Constantinou et al., 2010), the role of adherence
to treatment was explored. Treatment adherence was determined by participants’
self-reported 28-day substance use history.
At baseline, 12 patient participants reported using illicit opiates on top of
their prescribed substitute, while 11 reported not using on top. Table 4 displays
baseline data for participants using on top and not using on top alongside that for all
control participants.
Groups were compared on each variable in Table 4 using one-way ANOVAs,
and post-hoc Bonferroni adjusted comparisons were conducted across all groups to
identify significant group differences. There were significant differences in BDI-II
[F(2, 41) = 7.01, p = .002], PHQ-9 [F(2, 41) = 8.59, p = .001], and BIS-11 scores
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[F(2, 41) = 5.59, p = .007]. For the BIS-11 and PHQ-9 scores, participants using on
top had significantly greater scores on each measure than control participants (BIS-
11: p = .005; PHQ-9: p = .001). For the BDI-II score, both participants using on top
(p = .005) and not using on top (p = .028) had significantly higher scores than control
participants.
Table 4
Clinically relevant variables at baseline for opiate dependent participants who were
using on top, not using on top, and control participants.
Patient group Control group
Not using on top
(n=11)
Using on top
(n=12) (n=21) pa
Methadone dose 74.33 (44.14)b 54.64 (20.48)c -
BDI-II 21.1 (7.4) 23.3 (15.1) 9.6 (10.5) **
PHQ-9 10.1 (3.6) 13.9 (7.6) 5.1 (6.0) **
GAD-7 7.1 (6.0) 9.1 (7.3) 5.4 (5.0)
BIS-11 64.4 (14.0) 75.3 (17.1) 58.8 (11.0) **
VAS ‘like’ 1.2 (1.6) 4.2 (3.3) 0.4 (0.6) ***
VAS ‘want’ 1.2 (1.7) 3.7 (2.9) 0.3 (0.7) ***
VAS ‘urge’ 0.8 (1.47) 3.7 (3.2) 0.2 (0.5) ***
Note: Buprenorphine dose is not reported due to low numbers of participants in the non-abstinent
group (n=1).
a *p<.05, **p<.01, ***p<.001.
b n=6; the 5 other participants in this group were prescribed buprenorphine
c n=11; the 1 other participant in this group was prescribed buprenorphine
In addition, there were significant baseline differences in VAS ‘like’ [F(2,
41) = 15.53, p < .001], VAS ‘want’ [F(2, 41) = 13.39, p < .001] and VAS ‘urge’
[F(2, 41) = 14.71, p < .001]. In all cases participants using on top reported
significantly higher cravings than both those who did not use on top (like: p = .001;
want: p = .006; urge: p = .001) and control participants (all subscales: p < .001).
There was no significant difference in methadone dose between participants who did
and did not use on top [t(15) = 1.27, p = .222].
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Table 5 displays the number of patient participants using other illicit and licit
psychoactives in the two opiate dependent sub-groups. Due to the small numbers,
statistical analyses were precluded. However, inspection of Table 5 suggests a
preponderance (7/12) of those using illicit opiates on top also used crack, and all of
them reported using heroin and crack together. In the other sub-group, none were
using crack. For other substances, the groups were similar, although of the few that
were using alcohol, those that were using illicit opiates on top reported consuming
larger quantities. Owing to administration error, only quantity data for one of the
three benzodiazepine using participants in the using on top group were available,
thus preventing comparison between groups. Finally, there was great variation in the
quantities of different psychoactives used by different participants, as evidenced by
the large standard deviations.
Table 5
Number of patient participants using illicit substances on top of their prescribed
substitute, including mean quantity used over the past 28-days for each group.
Not using on top (N=11) Using on top (N=12)
n using Mean (SD) n using Mean (SD)
Opiates (g) - - 12 2.48 (2.64)
Crack cocaine (g) 0 - 7 1.87 (1.73)
Cannabis (n joints) 2 40.5 (55.86) 4 28.25 (26.79)
Alcohol (units per week) 4 7.00 (9.42) 3 43.67 (14.15)
Benzodiazepines (mg) 5a, b 181.00 (220.43) 3c, d 532.00 (0.00)
a 1 participant was on a reducing prescription for diazepam
b Quantity used data missing for 1 participant who reported using
c 2 participants were on a reducing prescription for diazepam
d Quantity used data missing for 2 participants who reported using
Table 6 displays the mean baseline AB scores for each group. When stimulus
duration was collapsed, there was a significant difference between groups on AB at
baseline [F(2, 41) = 3.67, p = .034] whereby participants not using on top had a
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significantly lower AB score than control participants (p = .050). The negative AB
score indicates that the attention of participants not using on top was drawn away
from opiate-related stimuli and towards neutral stimuli to a greater extent than
control participants. In addition, there was a trend-level difference between
participants who used on top and those that did not (p = .078), again with participants
who did not use on top showing lower AB relative to participants who did use on top.
When broken down by stimulus duration, there was a trend in the same direction for
stimuli presented at 500ms [F(2, 41) = 3.07, p = .057], but this was non-significant at
200ms [F(2, 41) = 1.03, p = .366].
In terms of patient participants’ use on top over time, this remained fairly
stable over the course of the study, as at one month follow-up, 10 reported using on
top, and 13 reported not using on top.
Table 6
Baseline attentional bias scores for patient participants who use on top, do not use
on top, and control participants.
Patient group Control group
Not using on top
(n=11)
Using on top
(n=12) (n=21) pa
AB at 200ms -31.63 (97.98) 11.68 (74.13) -6.57 (54.28)
AB at 500ms -46.56 (54.88) -4.34 (101.11) 11.16 (30.91)
AB (collapsed) -37.48 (52.98) 3.23 (53.35) 1.82 (26.31) *
a *p<.05, **p<.01, ***p<.001.
4.0 Discussion
The results of the present study did not support the main hypotheses.
Specifically, there was no immediate effect of ABM on AB in either opiate
dependent or control participants, nor was there any effect of ABM on AB over a one
month period in opiate dependent participants. There was also no immediate effect of
ABM on subjective craving in opiate dependent participants. Consequently,
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additional analyses on generalisation of ABM to novel stimuli, and on subjective
cravings and frequency of substance use over a one month follow-up period were not
conducted. However, these findings were in the context of the unexpected result that
there was no significant difference in baseline AB between opiate dependent and
control participants, which is contrary not only to the prior research indicating AB in
substance users in general (see Field & Cox, 2008), but also specifically in opiate
users relative to control participants (Constantinou et al., 2010; Fadardi & Ziaee,
2010; Franken et al., 2000; Lubman et al., 2000).
4.1 Possible reasons for non-significant findings
Secondary analyses conducted around treatment adherence for opiate
dependent participants went some way to illuminating the possible reason for these
non-significant findings. By examining the opiate dependent participants in terms of
whether or not they were using illicit opiates on top of their prescribed substitute,
some interesting group differences emerged. Specifically, those using illicit opiates
on top scored significantly higher at baseline than control participants on depressive
symptomatology and impulsivity. In addition, participants using on top had
significantly greater craving for substances at baseline than both patient participants
not using on top and control participants.
Clinically, the non-significant differences between participants not using on
top and control participants on measures of psychopathology and craving are also
very illuminating; participants not using on top in this study, although currently
opiate dependent, did not differ from control participants on measures of subjective
craving, impulsivity or on one of the measures of depression administered. In fact, on
the basis of the data presented here, participants not using on top and control
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participants were difficult to distinguish; there was only a significant difference on
one measure (BDI-II score).
There were also interesting findings from these secondary analyses in relation
to baseline AB. Here, participants not using on top showed a significant bias away
from substance-related stimuli and towards neutral stimuli relative to control
participants when data were collapsed across both 200 and 500ms stimulus durations.
In addition, there was a trend level difference between the same two groups at the
500ms duration (assessing controlled processing of attention), but no difference
between them at the 200ms stimulus duration (assessing automatic orienting of
attention). Taken together, this is suggestive that participants not using on top were
perhaps actively directing attention away from substances, whereas other participants
were not doing so. Although information about use on top beyond 28 days was not
gathered, this possibly accords with Constantinou et al.’s (2010) finding that ex-
opiate users showed a bias away from substance-related stimuli that correlated
positively with length of abstinence, and extends those findings to specify within
treatment differences that may be predictive of “recovery” (i.e. ex-opiate user status).
It is important to note, however, that the opiate-related stimuli used in the AB tasks
consisted of heroin and its paraphernalia, but not of methadone or buprenorphine.
This may, therefore, be another possible reason why participants not using on top did
not show a bias towards the opiate-related stimuli.
The results of these secondary analyses therefore provide a possible reason
for the null findings in relation to the major hypotheses. It seems that our sample of
opiate dependent participants were relatively ‘stable’ i.e. many reported not using on
top, and those who were had relatively low levels of opiate use on top of their
prescription. Indeed, this stability hypothesis is supported by the remarkably high
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retention rate of this group in this study (96% over one month), which, when
compared to other studies of a similar nature is particularly impressive and unusual.
For example, Schoenmakers and colleagues (2010), in their ABM study with alcohol
dependent participants, had a retention rate of 86% over an approximately two-week
period in which time the researchers had more than five separate contacts with them.
Fadardi and Cox (2009), in their ABM study with heavy drinkers had even poorer
retention rates for their heaviest drinking sub-group (60% after five weeks).
Therefore, had a greater proportion of our opiate dependent participants been using
on top, it is possible that significant results would have been found, both in terms of
baseline AB relative to control participants, and in terms of the effect of ABM on AB
and possibly on other variables such as subjective craving. Unfortunately, the present
sample was not large enough to explore these possibilities through running analyses
examining only participants using on top and control participants.
4.2 Methodological issues
An important caveat to the findings presented here is that of statistical power,
particularly with respect to the secondary analyses described above; since the opiate
dependent group was split for these analyses, quite low numbers of participants were
entered into some analyses. A priori power analysis was conducted for the effect of
ABM on AB, and not for the analyses reported in the secondary analysis section.
Therefore, the conclusions drawn from these analyses must be treated with caution.
However, it is possible the lack of significant findings with respect to the
main hypotheses was also due to low statistical power. While a priori power analysis
suggested that the sample size here ought to have been sufficient to detect an effect,
there remains the possibility that the effect size estimates used in this power
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calculation were inaccurate (i.e. larger than the true effect) given the relative infancy
of research in this area (see Button et al., 2013).
Some further possible contributory factors to both the lack of observed
baseline difference in AB and the lack of effect of ABM (which, it would be
hypothesised, should have modified AB regardless of baseline AB) lie in the
specifications of the AB task itself. While the general format of the tasks were
matched closely to those used in other studies, the duration of the tasks used to assess
AB at baseline and for the ABM tasks were briefer than many, thus possibly
preventing both the reliable assessment of AB and successful ABM. For example,
the task used to assess AB at baseline here had only 64 critical trials. While this is
comparable to most ABM studies (e.g. Field & Eastwood, 2005; Schoenmakers et
al., 2010; Schoenmakers et al., 2007), these studies have not compared AB in
substance users to non-users. In studies where such a comparison is made, the
number of trials is greater. For example, both Constantinou and colleagues (2010)
and Lubman and colleagues (2000) used visual probe tasks with 160 trials. In
addition, the ABM task used here, comprising 512 trials, was again briefer than is
commonly used. It was decided to make our ABM task briefer to avoid a very
lengthy testing session, as we reasoned this may have affected participant retention
and the quality of data collected amongst opiate dependent participants. We based
the specification of our ABM task loosely on that of Schoenmakers et al. (2010)
given that they also recruited a clinical sample. While their ABM task featured only
528 trials, it is noteworthy that they administered the task on five separate occasions,
thus increasing the number of trials to 2640. Therefore, for ABM to have been
successful, it may be the case that a greater number of trials were needed, either in
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one lengthy session (e.g. as per Field et al., 2007, who used 960 trials), or split
between multiple training sessions.
Another possible factor was the motivation of participants. Participants were
not informed of the experimental contingencies, in keeping with most of the
literature to date, and only one participant correctly identified the contingency.
Participants therefore may not have been well motivated, although no measure of
motivation was given to explicitly assess this. However, the extent to which
awareness and motivation are important is unclear, as mixed findings have been
reported. For instance, Field et al. (2009) found no significant effect of contingency
awareness, while both Schoenmakers et al. (2010) and Fadardi and Cox (2009)
explicitly informed participants of contingencies and reported positive results.
However, both of these latter studies also employed multiple sessions of ABM,
which may therefore have been a more important factor than awareness and
motivation.
4.3 Clinical and research implications
The results of the secondary analyses on treatment adherence raise several
important clinical implications. First, the data suggested high levels of depression in
participants who reported using on top. Indeed, the two might be related. It may
therefore be worthwhile services screening for depression in patients who are using
on top, or who begin using on top after a period of not doing so.
Second, while the differences in methadone dose did not reach statistical
significance, it is worth noting that there was a large difference between the mean
dose in participants who reported using on top and those who reported not using on
top. Specifically, those using on top had a mean dose of approximately 20mg less
and with less variance in dosage. Caution in interpretation of these figures is needed
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since the number of participants entered into this analysis was small, although it
raises the possibility that participants using on top were receiving an inadequate dose
of methadone which may have been contributing to their use on top. Indeed, there is
some evidence in the literature of better outcomes with higher doses. For example, a
randomised trial found that higher doses (80-100mg) were more effective in
achieving abstinence from additional, illicit heroin use and in achieving complete
detoxification compared to lower doses (40-50mg) (Strain, Bigelow, Liebson &
Stitzer, 1999). It is worth noting that the most successful dose in this trial (80-
100mg) is substantially greater than the mean dose of participants using on top in this
study (~55mg). In addition, the reduced use of illicit heroin on top in individuals
prescribed higher methadone doses is supported by a naturalistic study examining
opiate users in treatment across eight different substance misuse clinics (Trafton,
Minkel & Humphreys, 2006). Interestingly, this same study noted that effective
doses were positively correlated with the presence of psychopathology, including
self-reported levels of depression, leading the authors to recommend that clinical
factors such as the presence of depression should also be considered when
determining dosages.
Third, although no statistical comparisons were made, the data highlighted
the use of crack cocaine in addition to heroin as a particular problem. In this sample,
seven of the twelve participants who used illicit opiates on top of their
methadone/buprenorphine used crack cocaine in conjunction with these illicit
opiates, whereas no participants who were not using illicit opiates on top reported
using crack. This reflects current ‘street deals’ whereby heroin and crack are sold in
tandem. The data also highlighted alcohol consumption in larger quantities in those
participants who used illicit opiates on top. Services should therefore be alert to
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conjoint crack cocaine use and possible higher levels of alcohol consumption in
patients who are using illicit opiates on top of their prescribed substitute.
In terms of future research, several important considerations emerge from the
present study. First, any future ABM studies with opiate dependent individuals
should consider not using on top as an exclusion criterion to increase the likelihood
of ABM being useful in this group, since it is possible it is individuals who use on
top that have significant AB towards substances and significantly greater subjective
cravings. However, if participants who do not use on top are included in future
research, a second recommendation would be to include as stimuli images of
methadone and buprenorphine in AB tasks to examine whether such participants
exhibit an AB towards such images.
Third, the sample size in the present study was too small to conduct several
analyses of interest with regard to treatment adherence and other variables.
Therefore, in addition to repeating the analyses examining this study’s main
hypotheses in light of treatment adherence information, future studies with larger
samples may also wish to examine, for example, the association between AB and
subjective craving and methadone or buprenorphine dose at baseline, and the
differences in licit and illicit substance use (e.g. use of cannabis, alcohol, etc.)
between patients who do and do not use illicit opiates on top.
A fourth consideration would be the number of trials used in AB tasks. For
example, in ABM tasks, future research with this group should either utilise a greater
number of trials in a single session, or employ multiple training sessions each of
relatively briefer duration. While the use of multiple sessions may seem preferable
given the positive outcomes reported elsewhere in the literature, retention of
participants may then become an issue. Given the lack of significant effects found
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here, in the first instance it may be sensible to attempt a single, lengthier session with
multiple breaks to assess whether ABM is a fruitful avenue of research with this
population. Should it produce significant effects, it may then be better justified to
conduct a study examining the effect of multiple training sessions.
Finally, while the hypotheses of the present study were not supported by the
data, the clinical and conceptual implications of the secondary analyses’ findings are
nevertheless important. For instance, it may not be useful for both clinical or research
purposes to consider opiate dependent populations homogenous. Rather, patients
who use on top and patients who do not may be quite separable in terms of their
psychopathology and attentional functioning.
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Critical Appraisal
The process of completing this thesis, in both practical and academic
respects, has been interesting and challenging for many different reasons. This
appraisal aims to review the research process as a whole, and to hopefully provide
some practical guidance to researchers who are either already in, or who hope to
enter into the field of this thesis. Issues such as gaining ethical approval, joint
working and recruitment of clinical samples are discussed. How the experience of
doing the literature review and research impacted on my understanding of attentional
bias and the modification of other implicit processes will also be discussed.
Ethics Application Process
Prior to training in clinical psychology, I worked for two years as a research
assistant. This gave me good experience of many aspects of the research process.
However, one area I was not familiar with was ethics application to a National
Health Service Research Ethics Committee (NHS REC). While I was aware that the
process was longer than for internal university ethics application processes, nothing
could have prepared me for just how long it took! It goes without saying, therefore,
that a recommendation to others would be to start this early.
However, while the paperwork for this process was certainly laborious and
repetitive, it is important to note that progress was further hindered by a mandatory
internal review process within UCL, required in order for UCL to provide
sponsorship for research. In practical terms, this internal procedure (relevant to all
trainees applying for NHS ethics) amounted to our whole application requiring
approval twice. We were informed that we could not book a meeting with an NHS
REC until our application had been reviewed internally, which delayed our ability to
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approach an NHS REC by approximately six weeks. This was certainly frustrating,
but it was made more frustrating by the fact that some of the feedback given
regarding the application was inaccurate, and therefore complicated completion of
the form since clarification was required before proceeding. I believe this process is
something that needs reconsidering. After all, given that supervisors are Principal
Investigators on all NHS studies, is their sign-off on an application prior to
submission to an REC not sufficient? Trainees are not afforded a great deal of time to
conduct their research for their thesis owing to commitments to clinical placements;
the removal of this additional process would therefore allow for a valuable few
additional weeks of recruitment.
On another ethics related note, a point worthy of consideration before
approaching services is the method of paying participants. A question that was
regularly asked of us when discussing the research with staff in services was what
form payment would take, with a discussion emerging around the ethical
implications of paying substance users in cash and whether they should instead be
paid in vouchers. I understand the objection, and as an example I recall some
participants telling me that they only use heroin when they can afford to buy it i.e.
when they are paid their benefits. It may follow, therefore, that the £20 they received
from us may have gone towards funding their substance use. However, this would
not be true of all participants. My personal stance on this issue straightforward: I see
no ethical reason why substance users should not be paid in cash, in the same way as
control participants are. They are, after all, adults with capacity and are capable of
making their own decisions. Indeed, by inviting them to take part in research, we are
by definition seeing them as adults with capacity. Some may not consider their
decisions wise, but that is up to the individual. Whatever one decides regarding
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payment, however, it would be worthwhile preparing to communicate your reasoning
to services since this will certainly be required.
Shared Projects
The research project was conducted jointly with a fellow trainee clinical
psychologist and this was very helpful throughout the research process. Essentially, it
meant that the workload for each of us was halved, including completing forms for
the ethics application, gathering of research materials and recruitment and data
collection. Ensuring that each of us was available for testing on different days of the
week to one another also meant that we were able to increase our range of potential
participants, which was certainly a strength of the way that we worked together.
Joint working was not without its drawbacks, however, including the
occasional argument when we disagreed on a certain decision that needed to be
made. Sadly, this was often over relatively trivial things. Of course, this is inevitable
when two people spend often long periods of time with one another when both are
under a lot of stress. Fortunately, however, these occasions were few, and on the
whole, joint working was a very positive experience. After all, it is nothing but
entertaining when you have both spent the afternoon photographing heroin
paraphernalia in your flat, only for a flatmate to come home, find needles and dirty
spoons all over the kitchen, and have a look of shock and horror slowly spread across
their face as they think you have converted the place into a drug den!
Issues in Recruitment
Given the time constraints of data collection, an early start was imperative.
This was even truer given that we were recruiting both experimental and control
groups from clinical populations.
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I found the recruitment of each group to be surprising for very different
reasons and, in fact, the outcome was the opposite of what I predicted prior to
starting. I had expected that recruitment of opiate dependent participants would be
difficult, and also that retention of this group for follow-up sessions would be
challenging. On the contrary, recruitment went well with this group. While it was
true that there were a sizeable number of participants who did not attend their
appointment for the initial session of the research, there were still many who did
attend. Furthermore, only one participant failed to attend one of the follow-up
sessions; retention was otherwise seamless.
On the other hand, while I had expected recruitment of IAPT control
participants to run relatively smoother, this is not what happened. We instead found
that we struggled to accrue sufficient numbers, ultimately leading us to apply for
ethical approval to expand our potential pool of control participants to include
healthy individuals outside any treatment setting.
I think the reasons for this were varied. With respect to the opiate dependent
participants, the fact that we had an on-site supervisor who was a regular collaborator
on trainee research and who was very well-placed to get the study up-and-running
from the beginning helped a great deal. Being a regular collaborator meant that he
had a lot of research experience, particularly in terms of the practicalities of
recruiting and testing participants at the service where he works. His advice and
guidance were therefore extremely helpful. In fact, the whole team at the service
were very welcoming and friendly, and many of the key workers were very helpful in
the recruitment process by discussing the research with their patients and referring
interested persons on to us as researchers.
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One innovation which proved very useful was the approach that we took in
terms of our contact with the opiate dependent participants. Here, we mirrored the
service in that we took a more ‘assertive’ approach. What this meant was that we
would contact patients by telephone or text message regularly to remind them of
appointments. While this is very different to the way in which many services operate,
it was very effective in terms of ensuring attendance of participants. This was
evidenced by our very high retention rate (96% over one month) which is much
better than reported elsewhere in the literature on research with substance using
individuals.
Regarding control participants from the IAPT service, one factor that was not
originally considered was that many of the service’s patients are employed meaning
that testing during working hours was not feasible. While we did later arrange to test
during the evenings at a different location, we initially missed out on this
opportunity, thus slowing our recruitment down. In addition, given that our contacts
at the IAPT site were not as closely linked to the research as at the substance misuse
service, it meant we were able to spend less time on site making ourselves familiar to
both staff and potential participants, and therefore were not able to do as much
‘promotion’ of our study. In addition, we had hoped that expanding our recruitment
methods by gaining access to the IAPT service’s database of patients interested
research would lead to swifter recruitment. Again, however, I think reality did not
meet our expectations; we had perhaps anticipated many patients existing on this
database, when in fact we were initially passed the details for just seven people.
Taken together, these factors ultimately led to us widening our control sample to
include healthy participants. Again, offering testing sessions on evenings and
weekends was helpful, as these were the most opted-for of all of the appointments.
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Sample Size and Statistical Power
As discussed in Volume 1 Part 2 of this thesis, one possible significant
contributory factor to non-significant findings in the study was related to whether or
not opiate dependent participants were using illicit opiates on top of their prescribed
substitute medication. However, another point worthy of discussion is that of
statistical power. Although this was also discussed in Volume 1 Part 2, I think it is
worthy of an expanded discussion here. According to a priori calculations, the study
presented in this thesis was sufficiently powered to detect an effect. However, while
that is true, one cannot help but question whether or not that is indeed the case given
that the total sample size was still just 44, and less for some analyses. After all, the
two prior attentional bias modification (ABM) studies that offered effect size
estimates quoted Cohen’s d as 0.87 and 1.27. These figures are large and very large,
respectively (Cohen, 1992) and therefore for me seem rather unlikely; perhaps the
true effect size is very different, but given that there have been so few studies to date
it is possible that these estimates are inaccurate. Indeed, they are very different
between the two studies themselves.
A recent study led to my questioning of this. Button and colleagues (2013)
reviewed recent meta-analyses in neuroscience, and then using the estimated true
effect size given in these meta-analyses, retrospectively calculated the power of the
individual studies to detect these effects. What the authors found was startling: a
median statistical power of 21%. Granted, ABM research is not neuroscience and the
findings cannot be assumed to be true of other fields. However, there are more
general conceptual issues raised by the paper that apply to all research. For example,
the study highlighted how smaller studies tend to over-estimate the effect size of
significant results. Since initial studies in an area, often for funding reasons, tend to
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be small, it is therefore likely that an over-estimation of effect size occurs. A
consequence of this is that replication studies, which base their power analysis on
these effect size estimates, are therefore also likely to be underpowered. To
complicate the issue further, Button and colleagues highlight how low power not
only increases the risk of Type II errors, but also reduces the likelihood that a
statistically significant result reflects a true effect.
The same study also highlights the fact that low power, and therefore a low-
powered study, is closely associated with another bias that further complicates the
picture: the ‘vibration of effects’. This is a mathematical phenomenon in low-
powered studies, which gives rise to a large range of effect size estimates between
different studies. This may therefore explain the large discrepancy in effect size
estimates provided by previous ABM studies (see above).
Taken together, in an ideal world, any initial or early studies should aim to
have large sample sizes to increase power and obtain more accurate effect size
estimates for any significant findings. Provided replication studies then use formal
power calculations to determine sample size, this would facilitate effect size
estimates converging on the true effect size sooner rather than later. Of course, while
very important, practically this is very challenging.
How Conducting the Research Modified My Understanding of ABM
I found the process of conducting both the literature review and the research
project a very informative experience, and it brought to light several things of which
I was not previously aware in relation to modification of attentional bias and other
implicit processes.
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The Relative Success of Intervention across Different Disorders
I came into this research with prior experience of working in ABM as a
research assistant, although this experience was with participants with mood
disorders as opposed to substance misuse problems. The study that I was involved
with drew on research conducted with people with anxiety disorders. One of the
revealing and surprising things this thesis highlighted was the seemingly different
levels of success of ABM between people with mood/anxiety disorders and
substance users. For example, there are some very promising results regarding the
utility of ABM in anxiety disordered individuals, with individuals receiving ABM in
addition to usual treatment having better clinical outcomes relative to individuals in
control groups (see MacLeod, 2012, for a review). In substance users, however, this
does not appear to be as clear a finding. Specifically, the literature review highlighted
that while modifying implicit processes away from substance-related stimuli is
potentially helpful for substance using individuals, it seems from the evidence to date
that it is actually easier to create biases towards such stimuli, and ultimately
influence behaviour in a negative way. This was a surprising finding, but one that
was commonplace in control groups in different studies.
It is important to note, however, that research into ABM for substance use is
in its infancy relative to that of anxiety disorders. In time, and with refinement of the
methodology, the results may become comparable. However, this may not be the
case, and if so, exploration of the reasons would be very interesting. For example,
one might hypothesise that attentional bias in substance users may be more
biologically driven (if, as it is argued, it is a consequence of a process such as
incentive sensitisation; see Robinson & Berridge, 1993), making its modification
more difficult.
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Ways Forward with Intervention Research: Public Health Initiatives?
This raises interesting questions about the way to proceed in research of this
type, not only for opiate users, but for substance users more generally. It is certainly
worthwhile continuing to explore whether multiple sessions of ABM are helpful in
clinical groups of substance users, as it may indeed prove to be a useful adjunct to
regular treatments. However, it seems another way to address the problem would be
to take a public health approach, and rather than attempt to modify attentional bias in
substance users on an individual level one could take broader steps to remove the
environmental cues that grab attention.
Indeed, this is an approach that has been adopted in Australia in an effort to
reduce the rates of tobacco smoking. As of December 2012, all tobacco products sold
in Australia must be sold in plain packaging (The Parliament of the Commonwealth
of Australia, 2011). The evidence upon which this measure was based suggests that
plain packaging could reduce the number of young people taking up smoking (see
Quit Victoria, 2011). To date, data are not available on the relative success of the
measure due to the short time it has been in force, but such data will undoubtedly be
eagerly anticipated by other countries also considering the move. The British
government has also recently considered this for England, holding a consultation on
the matter in 2012. Although, rather disappointingly in my opinion, they recently
decided that further progress on the matter will be delayed. In any case, should
England and other nations eventually decide to take a similar approach, there will
almost certainly be a significant barrier to the process, namely the tobacco industry.
This industry remains very influential and powerful, and thus costly legal battles are
likely to ensue following the passing of any such law, as indeed is the case in
Australia.
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More broadly, while it is certainly a worthwhile enterprise to target tobacco
smoking with such interventions, one could make an argument that alcohol should
also be targeted in a similar manner. After all, there is some evidence from expert
opinion to suggest that alcohol is the most harmful substance in the UK above heroin
and crack cocaine (Nutt, King & Phillips, 2010). It is true that minimum pricing of
alcohol has been considered recently in England, although like plain packaging for
tobacco, the plans have been delayed. Similar to the Australian government over
tobacco packaging, other countries that have taken steps to implement a minimum
price for alcohol (e.g. Scotland) have faced lengthy and costly legal battles against
industry. It is possible political change to overrule competing demands of the
substance-producing industry as well as attitudinal change at a societal/cultural level
are required before these measures can be passed without such great opposition and
consequent great expense to the taxpayer.
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1 Attentional Bias/ 429 Advanced Display
More≫
2 attention* bias.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
1583 Advanced Display
More≫
3 implicit cogniti*.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
325 Advanced Display
More≫
4 implicit association test.mp. [mp=title, abstract, heading
word, table of contents, key concepts, original title,
tests & measures]
1441 Advanced Display
More≫
5 (attentio* adj2 modification).mp. [mp=title, abstract,
heading word, table of contents, key concepts, original
title, tests & measures]
99 Advanced Display
More≫
6 evaluative conditioning.mp. [mp=title, abstract, heading
word, table of contents, key concepts, original title,
tests & measures]
267 Advanced Display
More≫
7 approach avoidance.mp. or exp Approach Avoidance/ 1197 Advanced Display
More≫
8 implicit association*.mp. [mp=title, abstract, heading
word, table of contents, key concepts, original title,
tests & measures]
1605 Advanced Display
More≫
9 (implicit adj2 associatio*).mp. [mp=title, abstract,
heading word, table of contents, key concepts, original
title, tests & measures]
1684 Advanced Display
More≫
10 implicit attitude*.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
594 Advanced Display
More≫
11 memory bias.mp. 398 Advanced Display
More≫
12 action tendenc*.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
310 Advanced Display
More≫
13 cognitive bias modification.mp. 55 Advanced Display
More≫
14 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12
or 13
5881 Advanced Display
More≫
15 drug usage.mp. or exp Drug Usage/ 121691 Advanced Display
More≫
16 drug abuse.mp. or exp Drug Abuse/ 86069 Advanced Display
More≫
17 drug addiction.mp. or exp Drug Addiction/ 12864 Advanced Display
More≫
18 exp Drug Dependency/ 19832 Advanced Display
More≫
19 drug dependenc*.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
11358 Advanced Display
More≫
20 alcohol dependenc*.mp. [mp=title, abstract, heading
word, table of contents, key concepts, original title,
tests & measures]
6920 Advanced Display
More≫
21 exp alcohol drinking patterns/ or exp alcohol abuse/ 49481 Advanced Display
More≫
22 alcohol abuse.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
17829 Advanced Display
More≫
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23 alcohol drinking patterns.mp. [mp=title, abstract,
heading word, table of contents, key concepts, original
title, tests & measures]
16249 Advanced Display
More≫
24 problem drinking.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
1815 Advanced Display
More≫
25 tobacco smoking.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
20561 Advanced Display
More≫
26 smoking.mp. [mp=title, abstract, heading word, table of
contents, key concepts, original title, tests & measures]
33069 Advanced Display
More≫
27 cigarette smoking.mp. [mp=title, abstract, heading
word, table of contents, key concepts, original title,
tests & measures]
5180 Advanced Display
More≫
28 cannabis us*.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
2180 Advanced Display
More≫
29 heroin us*.mp. [mp=title, abstract, heading word, table
of contents, key concepts, original title, tests &
measures]
1621 Advanced Display
More≫
30 substance us*.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
20051 Advanced Display
More≫
31 substance abuse.mp. [mp=title, abstract, heading word,
table of contents, key concepts, original title, tests &
measures]
25149 Advanced Display
More≫
32 substance dependenc*.mp. [mp=title, abstract, heading
word, table of contents, key concepts, original title,
tests & measures]
1811 Advanced Display
More≫
33 substance addiction.mp. [mp=title, abstract, heading
word, table of contents, key concepts, original title,
tests & measures]
175 Advanced Display
More≫
34 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or
25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33
155924 Advanced Display
More≫
35 14 and 34 447 Advanced Display
More≫
36 limit 35 to ("0110 peer-reviewed journal" and english
and human)
340 Advanced Display
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Appendix B
The major research component of this thesis was a joint study conducted by
myself and a fellow Trainee Clinical Psychologist, Clare Wellington.
Workload related to our ethics application was shared equally. With the
support of our supervisor, we each independently designed the particular aspects of
our studies. Therefore, while the participants in each of our studies were the same,
we each had separate experimental tasks and hypotheses.
Data recruitment began in December 2012. Between this time and March
2013, Clare and I shared equal responsibility for the recruitment and testing of
participants. From March 2013 until the study’s completion, we had additional
assistance in data collection from Claire Mokrysz, PhD student in mental health,
University College London.
Data entry was shared by Clare Wellington and I, although data analysis was
conducted independently. Claire Mokrysz did not provide support in data entry or
data analysis.
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Participant Information Sheet (patient group)
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Appendix D
Participant Information Sheet (control group (IAPT))
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Appendix E
Participant Information Sheet (control group (healthy))
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Appendix F
Consent form (patient group)
APPENDIX F
118
Appendix G
Consent form (control group (IAPT))
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Appendix H
Consent form (control group (healthy))
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Appendix I
NHS REC ethical approval letter
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Appendix J
UCL PaLS ethical approval letter
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Appendix K
Barratt Impulsiveness Scale-11
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Appendix L
Visual Analogue Scales Used
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